Product Catalog
1771+ Pharmaceutical Products
All products sourced from WHO-GMP certified Indian manufacturers. Available for bulk export worldwide.
Showing top products per category. We can source any pharmaceutical product from certified Indian manufacturers.Request full catalog
Anti-Cancer
175 products available
TabletSorafenib 200mg
Sorafenib Tosylate
Soranib (Sorafenib 200mg) is an oral anti-cancer medicine that works by blocking abnormal protein signals that cause cancer cells to multiply. It helps stop or slow the spread of cancer in hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma. Available for global pharmaceutical export with WHO-GMP certification.
CapsuleLenalidomide 25mg
Lenalidomide
Lenalid (Lenalidomide 25mg) is an anti-cancer medicine that works by enhancing the immune system to attack cancer cells while preventing growth of new blood vessels within tumors. It is used for treatment of multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. Available in 5mg, 10mg, and 25mg capsule strengths for global pharmaceutical export.
TabletImatinib 400mg
Imatinib Mesylate
First-in-class BCR-ABL tyrosine kinase inhibitor that transformed CML from a fatal disease into a chronically manageable condition, achieving complete cytogenetic response in over 80% of newly diagnosed chronic-phase patients. It also targets c-KIT and PDGFR, making it the standard first-line treatment for unresectable or metastatic GIST and Ph+ ALL. Cipla and Sun Pharma manufacture affordable Indian generics in both 100mg and 400mg tablet strengths exported to oncology programmes worldwide.
TabletErlotinib 150mg
Erlotinib Hydrochloride
First-generation EGFR tyrosine kinase inhibitor that competitively blocks ATP binding to EGFR, suppressing downstream RAS-MAPK and PI3K-AKT tumour survival signalling in EGFR-mutant NSCLC. It is also approved at 100mg in combination with gemcitabine for locally advanced or metastatic pancreatic cancer, where it provides a modest but statistically significant survival benefit. Cipla and Glenmark supply export-quality generics in 100mg and 150mg tablets as affordable alternatives to Tarceva.
TabletGefitinib 250mg
Gefitinib
Geftinat (Gefitinib 250mg) is an anti-cancer medicine used to treat non-small cell lung cancer (NSCLC) with specific EGFR gene mutations. It works by blocking the action of abnormal proteins that signal cancer cells to multiply, helping stop or slow cancer progression. Available for global pharmaceutical export with WHO-GMP certification.
TabletCapecitabine 500mg
Capecitabine
Tumour-selective oral fluoropyrimidine prodrug converted to 5-FU preferentially within tumour cells by thymidine phosphorylase, providing targeted cytotoxic activity against colorectal, breast, and gastric cancers with convenient twice-daily oral dosing in 3-week cycles. It is approved as monotherapy and in combination with oxaliplatin (XELOX) or docetaxel for advanced gastrointestinal and breast malignancies. Cipla and Natco Pharma manufacture 500mg tablets to GMP standards for global oncology export programmes.
TabletAbiraterone 500mg
Abiraterone Acetate
Selective CYP17A1 inhibitor that blocks androgen biosynthesis in the testes, adrenal glands, and tumour tissue, suppressing testosterone to near-undetectable levels in castration-resistant prostate cancer. Co-administered with prednisone, it significantly extends overall survival in both mCRPC and metastatic castration-sensitive prostate cancer. Available in 250mg and 500mg tablets from Cipla and Glenmark as cost-effective generics to Zytiga for prostate oncology export.
CapsuleEnzalutamide 40mg
Enzalutamide
Enzamide (Enzalutamide 40mg) is an antiandrogen medicine used to treat prostate cancer that has spread or is resistant to hormone therapy. It works by blocking the effect of natural male hormones on the growth of prostate cells. Available in 40mg and 80mg capsule strengths for global pharmaceutical export.
TabletOsimertinib 80mg
Osimertinib Mesylate
Tagrisso (Osimertinib 80mg) is a targeted anti-cancer medicine used to treat non-small cell lung cancer (NSCLC) in patients with specific EGFR mutations. It works by blocking the action of abnormal proteins that signal cancer cells to multiply, helping slow disease progression. Available in 40mg and 80mg tablet strengths for global pharmaceutical export.
CapsulePalbociclib 125mg
Palbociclib
Palnat (Palbociclib 125mg) is an anti-cancer medicine that works by blocking proteins (CDK4/6) that control cancer cell growth, slowing tumor progression in hormone receptor-positive breast cancer. It is used in combination with an aromatase inhibitor or fulvestrant for HR-positive, HER2-negative advanced breast cancer. Available in 75mg, 100mg, and 125mg capsules for global pharmaceutical export.
TabletEverolimus 10mg
Everolimus
Torinat (Everolimus 10mg) is an anticancer medicine that works by reducing blood supply to tumors, slowing cancer cell growth and spread. It is used for treating advanced renal cell carcinoma, breast cancer, neuroendocrine tumors, and subependymal giant cell astrocytoma. Available in 5mg and 10mg tablet strengths for global pharmaceutical export.
CapsuleSunitinib 50mg
Sunitinib Malate
Sunitigen (Sunitinib 50mg) is an anti-cancer medicine that works by blocking cell surface proteins (tyrosine kinases) responsible for cancer growth and restricting tumor blood vessel development. It is used for advanced renal cell carcinoma, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors. Available in 12.5mg, 25mg, and 50mg capsules for global pharmaceutical export.
TabletLetrozole 2.5mg
Letrozole
Letoval (Letrozole 2.5mg) is an aromatase inhibitor used for treating breast cancer in postmenopausal women. It works by decreasing the amount of estrogen produced in the body to slow or stop the growth of estrogen-dependent breast cancers. Available for global pharmaceutical export with WHO-GMP certification.
CapsuleTemozolomide 250mg
Temozolomide
Oral imidazotetrazine alkylating agent that spontaneously converts to the active methylating species MTIC at physiological pH, inducing O6-methylguanine DNA adducts that cause tumour cell cycle arrest and apoptosis. Combined with radiotherapy, it constitutes the Stupp protocol — the established standard of care for newly diagnosed glioblastoma multiforme since 2005. Sun Pharma and Cipla export 20mg, 100mg, and 250mg capsules widely to neuro-oncology programmes across Asia, Africa, and Latin America.
InjectionBortezomib 3.5mg
Bortezomib
First-in-class reversible 26S proteasome inhibitor that disrupts protein homeostasis in malignant plasma cells and lymphoma cells, leading to accumulation of pro-apoptotic proteins and tumour cell death. It is a backbone agent in VRd and VCD regimens for newly diagnosed multiple myeloma and is approved for relapsed mantle cell lymphoma. Cipla and Hetero Drugs supply 2mg and 3.5mg lyophilized vials for IV or subcutaneous administration, exported globally to haematology units.
CapsuleDabrafenib 75mg
Dabrafenib Mesylate
Rafinlar (Dabrafenib 75mg) is an anti-cancer medicine that works by blocking the activity of BRAF, a mutated protein that regulates cell growth. It is used to treat melanoma, non-small cell lung cancer, and anaplastic thyroid cancer with BRAF V600E or V600K mutations. Available in 50mg and 75mg capsules for global pharmaceutical export.
CapsuleCrizotinib 250mg
Crizotinib
First-generation ALK/ROS1/MET tyrosine kinase inhibitor approved for ALK-positive and ROS1-positive metastatic NSCLC, delivering significant progression-free survival benefit over chemotherapy in first-line treatment. Natco and Cipla supply export-quality generics as affordable alternatives to Xalkori.
CapsuleIbrutinib 140mg
Ibrutinib
First-in-class irreversible Bruton tyrosine kinase inhibitor that disrupts B-cell receptor signalling, transforming outcomes in CLL/SLL, mantle cell lymphoma, and Waldenstrom macroglobulinemia. Indian generics from Natco Pharma provide this targeted haematological oncology agent at competitive export prices.
CapsuleNilotinib 200mg
Nilotinib Hydrochloride
Ninlib (Nilotinib 200mg) is an anti-cancer medicine that works by blocking abnormal signals in cancer cells, stopping them from growing. It is used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in newly diagnosed patients and those resistant to prior treatments. Available in 150mg and 200mg capsules for global pharmaceutical export.
CapsulePomalidomide 4mg
Pomalidomide
Third-generation immunomodulatory imide drug with enhanced anti-myeloma activity compared to thalidomide and lenalidomide, approved for relapsed/refractory multiple myeloma after at least two prior therapies including lenalidomide and bortezomib. Natco and Hetero supply affordable 1mg, 2mg, and 4mg capsules for global haematological oncology export.
TabletRegorafenib 40mg
Regorafenib
Oral multi-kinase inhibitor targeting angiogenic, stromal, and oncogenic receptor tyrosine kinases, approved for metastatic CRC after prior therapy, advanced GIST after imatinib and sunitinib, and hepatocellular carcinoma after sorafenib. Natco Pharma supplies affordable generics for oncology export markets.
TabletVenetoclax 100mg
Venetoclax
First-in-class selective BCL-2 inhibitor that restores apoptosis in CLL cells by displacing pro-apoptotic BIM protein, providing highly effective targeted therapy for CLL/SLL including 17p-deleted disease. Indian generics from Natco and Cipla offer access to this breakthrough haematological agent for export.
TabletDasatinib 70mg
Dasatinib
Second-generation dual SRC/ABL kinase inhibitor with 325-fold greater potency than imatinib against unmutated BCR-ABL, effective across most imatinib-resistant BCR-ABL mutations except T315I. Approved for newly diagnosed CML-CP and all phases of imatinib-resistant CML and Ph+ ALL. Cipla and Natco supply affordable generics for oncology export.
TabletTrametinib 2mg
Trametinib Dimethyl Sulfoxide
MEK1/MEK2 inhibitor used in combination with dabrafenib for BRAF V600-mutant melanoma and NSCLC. Manufactured by Natco and Cipla for affordable oncology export.
TabletRibociclib 200mg
Ribociclib Succinate
Selective CDK4/6 inhibitor for HR+/HER2- advanced breast cancer in combination with aromatase inhibitors or fulvestrant. Natco manufactures affordable generics for global oncology export.
Ponatinib 45mg
Ponatinib Hydrochloride
Third-generation BCR-ABL TKI specifically designed to overcome T315I gatekeeper mutation resistance in CML and Ph+ ALL. Natco Pharma supplies affordable generics for oncology export.
TabletCabozantinib 60mg
Cabozantinib S-Malate
Multi-kinase inhibitor targeting MET, VEGFR2, AXL, and RET pathways for advanced renal cell carcinoma and hepatocellular carcinoma. Cipla and Natco produce affordable generics for export.
CapsuleLarotrectinib 100mg
Larotrectinib Sulfate
First-in-class selective TRK inhibitor for NTRK gene fusion-positive solid tumors regardless of tumor type, representing tissue-agnostic oncology therapy. Manufactured by Indian generic companies for oncology export.
ED Medicines
123 products available
TabletSildenafil 100mg
Sildenafil Citrate
Selective cGMP-specific phosphodiesterase type 5 inhibitor that potentiates nitric oxide-mediated smooth muscle relaxation in penile vasculature, enabling erection in response to sexual stimulation within 30–60 minutes with a 4–6 hour therapeutic window. Available in 25mg, 50mg, and 100mg strengths, it is the world's most widely prescribed ED treatment and is also approved at 20mg for pulmonary arterial hypertension. Indian manufacturers Ajanta Pharma and Centurion Labs supply WHO-quality generics to global markets at highly competitive prices.
TabletTadalafil 20mg
Tadalafil
Long-acting PDE5 inhibitor with a 17.5-hour plasma half-life providing up to 36 hours of erectile response capability — earning it the 'weekend pill' distinction and superior adherence over shorter-acting agents. Its triple regulatory approval covering erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension makes it the most versatile agent in its class. Cipla and Ajanta Pharma manufacture 5mg, 10mg, and 20mg tablets for export as cost-effective alternatives to Cialis.
TabletVardenafil 20mg
Vardenafil Hydrochloride
Highly potent PDE5 inhibitor with an IC50 approximately 10-fold lower than sildenafil, delivering reliable onset within 25–60 minutes and a 4–5 hour efficacy window with a favourable food-independence profile. Available in 10mg and 20mg film-coated tablets and as an orally disintegrating sublingual tablet (Staxyn/Levitra ODT) for patients with swallowing difficulty. Sun Pharma and Centurion Labs manufacture Indian-generic vardenafil for international men's health export channels.
TabletAvanafil 200mg
Avanafil
Second-generation highly selective PDE5 inhibitor with the fastest clinical onset of any agent in its class (as early as 15 minutes pre-activity), achieved through rapid intestinal absorption and high PDE5 selectivity that reduces off-target effects on PDE6 and PDE1 — translating to fewer visual disturbances and cardiovascular side effects. Available in 50mg, 100mg, and 200mg strengths from Indian manufacturers Sunrise Remedies and Centurion Labs for men's health export markets.
TabletSildenafil + Dapoxetine
Sildenafil + Dapoxetine
Rational fixed-dose combination pairing sildenafil citrate 100mg for erectile dysfunction with dapoxetine HCl 60mg — a short-acting SSRI specifically approved for premature ejaculation — in a single tablet addressing both most common male sexual dysfunctions simultaneously. Taken 1–3 hours before activity, it delivers concurrent erection support and ejaculatory delay without requiring two separate prescriptions. Manufactured by Sunrise Remedies and Centurion Labs to export-grade quality for international men's health pharmacy channels.
TabletTadalafil + Dapoxetine
Tadalafil + Dapoxetine
Fixed-dose combination of tadalafil 20mg's extended 36-hour PDE5 inhibition with dapoxetine 60mg's rapid ejaculatory control, offering the unique advantage of a long therapeutic window for erection alongside acute PE management in a single tablet. This combination is particularly favoured in markets where both conditions co-exist in a significant proportion of men presenting to sexual health clinics. Sunrise Remedies and Centurion Labs supply this product to regulated international export markets.
Oral JellyKamagra Oral Jelly
Sildenafil Citrate
Sildenafil citrate 100mg in a palatable oral gel sachet formulation that bypasses first-pass metabolism more rapidly than conventional tablets, achieving pharmacologically active plasma levels within 15–30 minutes — significantly faster than standard film-coated tablets. Each flavoured 5g sachet is squeezed directly onto the tongue or into a spoon, making it ideal for patients with dysphagia or those preferring a tablet-free format. Manufactured by Ajanta Pharma and exported in 7-sachet boxes to men's health markets worldwide.
TabletCenforce 200mg
Sildenafil Citrate
Centurion Laboratories' premium sildenafil citrate brand offered in 100mg, 150mg, and 200mg high-strength formulations designed for cases of moderate-to-severe erectile dysfunction that do not respond adequately to standard 50mg doses. The 200mg strength provides maximum PDE5 inhibition for patients with organic vascular ED, diabetic ED, or post-prostatectomy ED, where higher plasma drug concentrations are clinically warranted. Each blister strip of 10 tablets is manufactured to GMP standards and exported globally through regulated pharmaceutical channels.
TabletVidalista 60mg
Tadalafil
Centurion Laboratories' tadalafil brand in an extended range of 20mg, 40mg, and 60mg strengths, providing titrated dosing flexibility for men requiring greater PDE5 inhibitory coverage than the standard 20mg dose allows — including those with severe vascular ED, diabetes-related ED, or inadequate response to first-line dosing. The long 36-hour half-life is preserved at all strengths, maintaining the 'weekend pill' advantage. Exported in 10-tablet blister strips to regulated international pharmacy markets.
TabletDapoxetine 60mg
Dapoxetine Hydrochloride
Short-acting SSRI uniquely developed and approved specifically for on-demand treatment of premature ejaculation — the only pharmacological agent with a dedicated regulatory indication for PE in men aged 18–64. Its rapid absorption (Tmax ~1.3 hours) and short half-life (~1.3 hours) make it pharmacokinetically ideal for as-needed dosing rather than chronic daily therapy, distinguishing it from other SSRIs. Sun Pharma and Sunrise Remedies manufacture 30mg and 60mg tablets exported to international urology and men's health markets.
TabletUdenafil 100mg
Udenafil
Long-acting PDE5 inhibitor with onset within 30 minutes and duration up to 24 hours, offering a therapeutic window between sildenafil and tadalafil for erectile dysfunction management. Manufactured by Indian pharmaceutical companies for export to global men's health markets.
TabletTadalafil 5mg Daily
Tadalafil
Low-dose daily tadalafil regimen providing continuous PDE5 inhibition for treatment of both ED and lower urinary tract symptoms associated with BPH, eliminating the need for timed dosing before sexual activity. Manufactured by Cipla and Sun Pharma as a widely exported dual-indication men's health product.
ODT TabletSildenafil 25mg ODT
Sildenafil Citrate
Orally disintegrating tablet formulation of sildenafil that dissolves on the tongue without water, providing convenience and faster onset for patients who prefer not to swallow conventional tablets. Manufactured by Ajanta Pharma for export to global ED treatment markets.
Mirodenafil 100mg
Mirodenafil
PDE5 inhibitor with rapid onset within 20 minutes and a favorable safety profile for erectile dysfunction treatment. Manufactured by Indian pharmaceutical companies for men's health export.
TabletTadalafil + Dapoxetine 20/30mg
Tadalafil + Dapoxetine
Dual-action combination tablet addressing both erectile dysfunction and premature ejaculation simultaneously. Manufactured by Sunrise Remedies and Centurion Labs for export.
ODT TabletVardenafil 10mg ODT
Vardenafil Hydrochloride
Orally disintegrating formulation of vardenafil providing rapid absorption without water, convenient for patients who prefer not to swallow tablets. Manufactured by Cipla for global export.
InjectionAlprostadil 20mcg Injection
Alprostadil
Prostaglandin E1 injection for intracavernosal use in ED patients who are unresponsive to oral PDE5 inhibitors. Manufactured by Sun Pharma and Cipla for urology export.
Antibiotics
130 products available
TabletAzithromycin 500mg
Azithromycin
Azalide subclass macrolide antibiotic that achieves exceptionally high and sustained intracellular tissue concentrations — up to 100-fold higher than plasma levels — enabling short 3-day or 5-day treatment courses for respiratory, skin, and sexually transmitted bacterial infections. Its anti-inflammatory properties beyond direct bacteriostasis provide additional clinical benefit in community-acquired pneumonia. Cipla and Alkem Labs manufacture 250mg and 500mg tablets exported globally as a staple of primary care antibiotic formularies.
CapsuleAmoxicillin 500mg
Amoxicillin Trihydrate
Aminopenicillin with extended gram-positive and gram-negative bactericidal activity, offering superior oral bioavailability (~90%) compared to ampicillin and the convenience of twice- or thrice-daily dosing for common community infections of the respiratory tract, urinary tract, skin, and ear. It is also a key component of H. pylori triple-eradication therapy and is a WHO Essential Medicine available in both capsule and dispersible tablet forms. Cipla and GSK manufacture 250mg and 500mg capsules exported to primary care markets globally.
TabletAugmentin 625mg
Amoxicillin + Clavulanate
Fixed-dose combination of amoxicillin with clavulanic acid, a potent beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation and restores its activity against beta-lactamase-producing strains of Staphylococcus, Haemophilus, Moraxella, and Klebsiella commonly encountered in community and hospital settings. Widely prescribed for sinusitis, otitis media, lower respiratory infections, UTIs, animal bites, and dental abscesses resistant to amoxicillin alone. GSK and Cipla supply 625mg and 1g tablets exported as a primary care antibiotic staple worldwide.
TabletCiprofloxacin 500mg
Ciprofloxacin Hydrochloride
Second-generation fluoroquinolone with broad-spectrum bactericidal activity mediated through dual inhibition of bacterial DNA gyrase and topoisomerase IV, achieving excellent tissue penetration into the urinary tract, prostate, GI tract, bone, and lung. It remains the drug of choice for uncomplicated UTIs, traveller's diarrhoea, typhoid fever, and anthrax prophylaxis, and is a WHO Essential Medicine. Cipla and Sun Pharma manufacture 250mg, 500mg, and 750mg tablets exported to primary care and hospital formularies globally.
TabletLevofloxacin 500mg
Levofloxacin
Optically pure L-isomer of ofloxacin with enhanced gram-positive activity — particularly against Streptococcus pneumoniae — that makes it the preferred fluoroquinolone for community-acquired pneumonia, acute bacterial sinusitis, and chronic bacterial prostatitis under major international respiratory guidelines. Its once-daily dosing and availability in IV and oral formulations with equivalent bioavailability facilitates seamless step-down therapy. Cipla and Glenmark manufacture 250mg, 500mg, and 750mg tablets exported to hospital and primary care markets globally.
CapsuleDoxycycline 100mg
Doxycycline Hyclate
Long-acting tetracycline class antibiotic that inhibits bacterial 30S ribosomal protein synthesis, with broad activity spanning gram-positive, gram-negative, atypical, and intracellular organisms including Chlamydia, Rickettsia, Borrelia, and Plasmodium falciparum. Its dual utility as both an antibiotic and anti-inflammatory agent makes it the preferred systemic treatment for acne vulgaris and rosacea, while its malaria prophylaxis indication supports tropical export markets. Cipla and Sun Pharma supply 100mg capsules widely exported globally.
InjectionCeftriaxone 1g Injection
Ceftriaxone Sodium
Third-generation injectable cephalosporin with an exceptionally long 8-hour half-life enabling once-daily IV or IM dosing, exceptional CNS penetration making it first-line for bacterial meningitis, and broad coverage of gram-positive and gram-negative pathogens including Enterobacteriaceae. It is among the most widely used parenteral antibiotics globally and a WHO Essential Medicine for hospital-acquired and severe community-acquired infections. Cipla and Lupin manufacture 250mg to 2g vials exported to hospital formularies worldwide.
InjectionMeropenem 1g Injection
Meropenem Trihydrate
Ultra-broad-spectrum carbapenem with activity against virtually all clinically significant gram-positive, gram-negative, and anaerobic organisms including ESBL- and AmpC-producing Enterobacteriaceae that resist third-generation cephalosporins. Unlike imipenem, it has intrinsic stability to renal DHP-1 and does not require cilastatin co-administration, and its superior CNS penetration makes it first-choice for nosocomial meningitis. Cipla and Aristo Pharma export 500mg and 1g vials to ICU and hospital infectious disease programmes worldwide.
TabletLinezolid 600mg
Linezolid
First-in-class oxazolidinone antibiotic that inhibits bacterial protein synthesis at a unique ribosomal step (50S subunit formation), with no cross-resistance to other antibiotic classes, making it a critical reserve agent for MRSA, vancomycin-resistant Enterococcus, and multidrug-resistant tuberculosis. Its oral bioavailability of approximately 100% enables seamless IV-to-oral step-down therapy with equivalent serum levels, a key clinical advantage in MDR infection management. Cipla and Glenmark supply 600mg tablets exported to infectious disease and MDR-TB programmes worldwide.
TabletMetronidazole 400mg
Metronidazole
Nitroimidazole prodrug selectively reduced to a cytotoxic radical in anaerobic and microaerophilic organisms, damaging microbial DNA with potent bactericidal and antiprotozoal activity against Bacteroides, Trichomonas, Giardia, Entamoeba, and H. pylori. Its dual antibacterial and antiprotozoal spectrum, high tissue bioavailability, and low cost make it an indispensable WHO Essential Medicine for gastrointestinal, gynaecological, dental, and surgical infection management. Cipla and Alkem Labs manufacture 200mg, 400mg, and 500mg tablets exported to primary care markets across Africa, Asia, and Latin America.
CapsuleClindamycin 300mg
Clindamycin Hydrochloride
Lincosamide antibiotic with exceptional bone, joint, and soft tissue penetration that inhibits bacterial 50S ribosomal protein synthesis, providing excellent activity against aerobic gram-positive cocci including community-acquired MRSA and a broad range of anaerobes. It is the preferred oral antibiotic for MRSA skin and soft tissue infections, bone and joint infections, and dental abscesses in penicillin-allergic patients, and is a key component of toxoplasmosis treatment regimens. Cipla and Glenmark manufacture 150mg and 300mg capsules exported to hospital and community antibiotic programmes globally.
InjectionVancomycin 500mg Injection
Vancomycin Hydrochloride
Tricyclic glycopeptide antibiotic that inhibits bacterial cell wall synthesis at a late transglycosylation step distinct from beta-lactams, retaining activity against all clinically significant MRSA strains and remaining the gold-standard parenteral treatment for MRSA bacteraemia, endocarditis, meningitis, and pneumonia. Its non-absorbed oral form is used specifically for Clostridioides difficile colitis. Modern AUC/MIC pharmacokinetic monitoring optimises efficacy while limiting nephrotoxicity. Cipla and Alkem Labs supply 500mg and 1g vials exported to hospital infectious disease programmes worldwide.
InjectionPiperacillin + Tazobactam 4.5g Injection
Piperacillin + Tazobactam
Anti-pseudomonal ureidopenicillin (piperacillin) paired with the beta-lactamase inhibitor tazobactam, delivering one of the broadest parenteral antibiotic spectrums including Pseudomonas aeruginosa, ESBL-negative Enterobacteriaceae, anaerobes, and most gram-positive organisms relevant in nosocomial infections. It is the preferred empiric agent for febrile neutropenia, complicated intra-abdominal infections, diabetic foot infections, and hospital-acquired pneumonia in many international guidelines. Cipla and Lupin export 2.25g and 4.5g vials to intensive care and surgical ward formularies globally.
InjectionAmikacin 500mg Injection
Amikacin Sulfate
Semi-synthetic aminoglycoside with the broadest resistance profile in its class — it retains bactericidal activity against gentamicin- and tobramycin-resistant gram-negative organisms due to resistance to most aminoglycoside-modifying enzymes. It is a WHO Essential Medicine indicated for serious Pseudomonas, Acinetobacter, and Klebsiella infections, and is an important component of MDR-TB treatment regimens. Cipla and Alkem Labs supply 250mg and 500mg vials exported to critical care and infectious disease programmes globally.
TabletRifaximin 550mg
Rifaximin
Minimally absorbed rifamycin-class antibiotic that acts locally within the GI lumen by inhibiting bacterial RNA polymerase, achieving high intraluminal antibiotic concentrations while avoiding systemic drug exposure and associated systemic side effects. Its three distinct approved indications — traveller's diarrhoea (200mg), hepatic encephalopathy prevention (550mg), and IBS-D (550mg) — across gastroenterology and hepatology make it uniquely versatile. Sun Pharma and Lupin manufacture 200mg, 400mg, and 550mg tablets exported to gastroenterology markets globally.
InjectionColistimethate 1MU Injection
Colistimethate Sodium
Last-resort polymyxin antibiotic re-introduced for treatment of multidrug-resistant Gram-negative infections including carbapenem-resistant Acinetobacter, Pseudomonas, and Klebsiella. Manufactured by Cipla and Sun Pharma for hospital ICU formularies and exported globally for critical care infection management.
InjectionTigecycline 50mg Injection
Tigecycline
First-in-class glycylcycline antibiotic with broad-spectrum activity against MRSA, VRE, ESBL-producers, and anaerobes, approved for complicated skin/soft tissue and intra-abdominal infections. Manufactured by Cipla and Glenmark for hospital formulary export to critical care markets worldwide.
InjectionErtapenem 1g Injection
Ertapenem Sodium
Once-daily Group 1 carbapenem with broad activity against ESBL-producing Enterobacteriaceae, anaerobes, and common Gram-positives but lacking Pseudomonas and Acinetobacter coverage, making it suitable for step-down and community-onset infections. Manufactured by Sun Pharma and Cipla for export to hospital pharmacy channels globally.
InjectionDoripenem 500mg Injection
Doripenem
Ultra-broad-spectrum carbapenem with enhanced stability against renal dehydropeptidase and potent activity against Pseudomonas aeruginosa, approved for complicated UTI and intra-abdominal infections. Manufactured by Cipla and Glenmark for ICU and hospital-based infection management in export markets.
CapsuleNitrofurantoin 100mg
Nitrofurantoin
Synthetic nitrofuran antibiotic concentrated in urine to bactericidal levels against common uropathogens including E. coli, with minimal impact on gut flora and low resistance development, making it a first-line choice for uncomplicated UTI and long-term prophylaxis. Manufactured by Cipla and Sun Pharma for global urology and primary care export markets.
Granules for oral solutionFosfomycin 3g Sachet
Fosfomycin Trometamol
Phosphonic acid antibiotic with unique cell wall synthesis inhibition mechanism providing single-dose oral treatment for uncomplicated UTI, with activity against many ESBL-producing and MDR uropathogens. Manufactured by Cipla and Lupin as a convenient single-dose UTI treatment for export to primary care and women's health markets.
TabletTedizolid 200mg
Tedizolid Phosphate
Next-generation oxazolidinone antibiotic with enhanced potency against MRSA and VRE compared to linezolid, offering shorter 6-day course with once-daily dosing and reduced myelosuppression risk. Manufactured by Cipla and Glenmark for hospital formulary export in acute bacterial skin and skin structure infection management.
TabletCefpodoxime 200mg
Cefpodoxime Proxetil
Third-generation oral cephalosporin with broad-spectrum activity against respiratory and urinary pathogens. Manufactured by Lupin and Cipla as a widely exported oral antibiotic.
TabletCefixime 200mg
Cefixime
Third-generation oral cephalosporin with extended spectrum against gram-negative organisms, commonly used for gonorrhea and respiratory infections. Manufactured by Mankind and Cipla for export.
TabletClarithromycin 500mg
Clarithromycin
Macrolide antibiotic used in H. pylori eradication triple therapy and respiratory tract infections. Manufactured by Cipla and Sun Pharma for global antibiotic export.
InjectionColistimethate 1MU Injection
Colistimethate Sodium
Polymyxin antibiotic reserved as last-resort treatment for MDR gram-negative infections including carbapenem-resistant organisms. Manufactured by Cipla and Glenmark for ICU export.
Anti-Depressant & Anxiety
100 products available
TabletEscitalopram 10mg
Escitalopram Oxalate
Highly selective S-enantiomer of citalopram with superior serotonin reuptake inhibition and a cleaner off-target profile than the racemate, making it one of the best-tolerated and most prescribed SSRIs worldwide for both major depressive disorder and generalised anxiety disorder. Once-daily dosing, rapid onset (2–4 weeks), and predictable pharmacokinetics without clinically significant CYP interactions distinguish it from older SSRIs. Cipla and Sun Pharma manufacture 5mg, 10mg, and 20mg tablets exported globally for psychiatry and primary care markets.
TabletSertraline 100mg
Sertraline Hydrochloride
SSRI with the broadest approved psychiatric indication set of any antidepressant — covering major depressive disorder, OCD, panic disorder, PTSD, social anxiety disorder, and premenstrual dysphoric disorder — making it the most versatile agent in its class for mental health export markets. Its favourable tolerability profile, low drug interaction potential, and availability in three strengths from 25mg to 100mg support flexible dosing for diverse patient populations. Cipla and Sun Pharma manufacture sertraline tablets exported to psychiatry and primary care markets globally.
CapsuleDuloxetine 60mg
Duloxetine Hydrochloride
Balanced serotonin-norepinephrine reuptake inhibitor with equal affinity for both transporters, addressing the emotional and physical symptom dimensions of depression and anxiety while providing independent analgesic benefit in diabetic peripheral neuropathy and fibromyalgia through descending pain pathway modulation. Its five distinct approved indications — MDD, GAD, DPNP, fibromyalgia, and chronic musculoskeletal pain — make it one of the most clinically versatile antidepressants available. Sun Pharma and Intas Pharmaceuticals manufacture 20mg, 30mg, and 60mg enteric-coated capsules exported globally.
CapsulePregabalin 75mg
Pregabalin
Alpha-2-delta calcium channel ligand that reduces neuronal excitability and central sensitisation by decreasing presynaptic release of excitatory neurotransmitters including glutamate, substance P, and noradrenaline, delivering analgesic, anxiolytic, and anticonvulsant effects through a single mechanism. Approved across four distinct indications — diabetic and postherpetic neuropathic pain, fibromyalgia, generalised anxiety disorder, and adjunct epilepsy — with a rapid 1-week onset for pain relief. Sun Pharma and Cipla manufacture 50mg to 300mg capsules widely exported to neurology and pain management markets.
TabletModafinil 200mg
Modafinil
Eugeroic (wakefulness-promoting) agent with a mechanism distinct from amphetamines — primarily inhibiting dopamine reuptake with additional orexinergic and noradrenergic activity — providing sustained wakefulness without the cardiovascular stimulation, euphoria, or abuse potential characteristic of classical stimulants. Approved for narcolepsy, adjunct OSA management, and shift work sleep disorder, it is also widely prescribed off-label for cognitive enhancement and fatigue in oncology and MS patients. Sun Pharma and HAB Pharma manufacture 100mg and 200mg tablets exported globally.
TabletBupropion SR 150mg
Bupropion Hydrochloride
Norepinephrine-dopamine reuptake inhibitor (NDRI) that is clinically distinct from SSRIs and SNRIs — it carries no serotonergic sexual side effects, does not cause weight gain, and has a proven dual indication for both major depressive disorder and smoking cessation (as Zyban), making it the preferred antidepressant for patients concerned about weight or sexual function. Extended-release SR and XL formulations enable once- or twice-daily dosing with consistent plasma levels. Sun Pharma and Cipla manufacture 150mg SR and 300mg XL tablets exported to psychiatry markets globally.
CapsuleFluoxetine 20mg
Fluoxetine Hydrochloride
The original SSRI with a uniquely long plasma half-life (1–4 days parent, 4–16 days active metabolite norfluoxetine), virtually eliminating discontinuation syndrome upon stopping and allowing flexible weekly dosing in selected patients. Beyond MDD and OCD, it is the only SSRI specifically approved for bulimia nervosa and is used in combination with olanzapine for bipolar depression. Cipla and Torrent Pharma manufacture 10mg, 20mg, and 40mg capsules exported as a highly affordable antidepressant to psychiatry markets worldwide.
CapsuleVenlafaxine XR 75mg
Venlafaxine Hydrochloride
First-in-class SNRI with dose-dependent pharmacological activity — serotonin reuptake inhibition at 75mg and dual serotonin plus norepinephrine reuptake inhibition at 150–225mg, allowing a tailored therapeutic approach. Approved for MDD, GAD, social anxiety disorder, and panic disorder, the extended-release XR formulation simplifies dosing to once daily with a more favourable GI tolerability profile. Sun Pharma and Torrent Pharma manufacture 37.5mg, 75mg, and 150mg XR capsules exported to psychiatry markets globally.
TabletAmitriptyline 25mg
Amitriptyline Hydrochloride
Tertiary amine tricyclic antidepressant that inhibits serotonin and norepinephrine reuptake while also blocking muscarinic, histamine H1, and alpha-1 receptors, producing potent analgesia and sedation that make it particularly effective for neuropathic pain, migraine prophylaxis, and insomnia at low doses (10–25mg) below the antidepressant range. Its breadth of off-label analgesic indications — including DPNP, postherpetic neuralgia, IBS, and interstitial cystitis — drives significant export demand for all four tablet strengths. Cipla and Alkem Labs manufacture 10mg to 75mg tablets exported globally.
TabletMirtazapine 30mg
Mirtazapine
Noradrenergic and specific serotonergic antidepressant (NaSSA) that enhances noradrenergic and serotonergic neurotransmission through alpha-2 autoreceptor blockade, without inhibiting monoamine reuptake and thus avoiding the sexual dysfunction and GI side effects common to SSRIs and SNRIs. Its potent H1 antihistamine activity provides clinically useful sedation and appetite stimulation, making it the preferred antidepressant for depressed patients with insomnia, anxiety, or significant weight loss. Sun Pharma and Torrent Pharma manufacture 7.5mg, 15mg, and 30mg tablets exported globally to psychiatry markets.
TabletArmodafinil 150mg
Armodafinil
Pharmacologically active R-enantiomer of racemic modafinil with a longer plasma half-life and a more consistent late-day plasma concentration profile than its racemate, resulting in sustained wakefulness throughout the work day without the afternoon dip sometimes seen with modafinil. Approved for narcolepsy, adjunct OSA management, and shift work sleep disorder in a single 150mg once-daily tablet, it is preferred by many clinicians for its improved pharmacokinetic profile. Sun Pharma and HAB Pharma manufacture 50mg and 150mg tablets exported globally.
TabletZopiclone 7.5mg
Zopiclone
Cyclopyrrolone non-benzodiazepine hypnotic (Z-drug) that acts at the GABA-A receptor complex to reduce sleep latency, increase total sleep time, and improve sleep quality, with a shorter half-life (~5 hours) than most benzodiazepines that minimises next-morning residual sedation at the standard 7.5mg dose. The 3.75mg half-tablet dosing is appropriate for elderly patients and those with hepatic impairment. Sun Pharma and HAB Pharma manufacture 3.75mg and 7.5mg tablets exported to sleep medicine markets globally.
TabletParoxetine 20mg
Paroxetine Hydrochloride
Selective serotonin reuptake inhibitor with potent anxiolytic properties, widely prescribed for major depressive disorder, generalized anxiety disorder, panic disorder, social anxiety, OCD, and PTSD. Manufactured by Sun Pharma and Cipla for export to global psychiatric and primary care markets.
TabletTrazodone 50mg
Trazodone Hydrochloride
Serotonin antagonist and reuptake inhibitor (SARI) with dose-dependent sedative and antidepressant properties, widely used at low doses for insomnia and at higher doses for major depressive disorder. Manufactured by Sun Pharma and Torrent for export to psychiatric and sleep medicine markets.
TabletBuspirone 10mg
Buspirone Hydrochloride
Non-benzodiazepine anxiolytic acting as a 5-HT1A partial agonist, providing anxiolytic efficacy without sedation, dependence, or withdrawal risk associated with benzodiazepines. Manufactured by Sun Pharma and Cipla for export to anxiety disorder management programs worldwide.
TabletClomipramine 25mg
Clomipramine Hydrochloride
Tricyclic antidepressant with potent serotonergic activity considered the gold-standard pharmacotherapy for obsessive-compulsive disorder, with demonstrated superiority over SSRIs in severe OCD. Also used for panic disorder, depression, and cataplexy. Manufactured by Sun Pharma and Cipla for neuropsychiatric export markets.
TabletAgomelatine 25mg
Agomelatine
Novel antidepressant with dual melatonergic MT1/MT2 agonist and 5-HT2C antagonist mechanism, restoring circadian rhythm disruption underlying depression while improving sleep architecture without sedation or sexual dysfunction. Manufactured by Sun Pharma and Intas for export to psychiatric markets globally.
CapsuleVenlafaxine 150mg XR
Venlafaxine Hydrochloride
SNRI antidepressant in extended-release formulation for once-daily dosing in major depression, GAD, and social anxiety. Manufactured by Cipla and Sun Pharma for psychiatric export.
TabletEscitalopram 20mg
Escitalopram Oxalate
S-enantiomer of citalopram offering superior serotonin reuptake selectivity for depression and anxiety with the cleanest side-effect profile among SSRIs. Manufactured by Cipla and Torrent for export.
TabletTrazodone 100mg
Trazodone Hydrochloride
SARI antidepressant widely used at low doses for insomnia and at higher doses for major depression. Manufactured by Sun Pharma and Torrent for psychiatric and sleep medicine export.
TabletDesvenlafaxine 50mg
Desvenlafaxine Succinate
Active metabolite of venlafaxine with more predictable pharmacokinetics and fewer drug interactions. Manufactured by Sun Pharma and Torrent for psychiatric export.
TabletClomipramine 75mg
Clomipramine Hydrochloride
Higher-strength tricyclic antidepressant considered the gold-standard for severe OCD, offering potent serotonergic activity. Manufactured by Sun Pharma and Cipla for neuropsychiatric export.
Skin Care & Dermatology
94 products available
CreamTretinoin Cream 0.05%
Tretinoin
First-line topical retinoid that accelerates epidermal cell turnover, making it highly effective for acne vulgaris, photoaging, and post-inflammatory hyperpigmentation. Available in three concentrations from leading Indian manufacturers, this export-grade formulation meets international dermatology standards for patients seeking clinically proven skin renewal therapy.
CapsuleIsotretinoin 20mg
Isotretinoin
Oral retinoid reserved for severe nodular and cystic acne that is unresponsive to systemic antibiotics and topical treatments, capable of producing complete and long-lasting remission. Supplied as soft gelatin capsules from certified Indian manufacturers in multiple strengths for precise weight-based dosing in compliance with international treatment protocols.
SolutionMinoxidil 5% Solution
Minoxidil
Topical potassium channel opener that prolongs the anagen (growth) phase of hair follicles, clinically proven to halt androgenetic alopecia progression and stimulate visible regrowth in both men and women. Available in 2%, 5%, and 10% concentrations as a ready-to-use scalp solution, manufactured by leading Indian pharmaceutical companies for export to global hair-loss markets.
CreamHydroquinone 4% Cream
Hydroquinone
Tyrosinase-inhibiting depigmenting agent that effectively reduces melanin production in hyperpigmented skin, prescribed for melasma, post-inflammatory hyperpigmentation, solar lentigines, and age spots. Available in 2% and 4% concentrations from trusted Indian manufacturers, this export-grade formulation is widely used in dermatology practices across Southeast Asia, Africa, and Latin America.
TabletFinasteride 1mg
Finasteride
Type II 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), addressing the hormonal root cause of male androgenetic alopecia and benign prostatic hyperplasia. Exported in 1mg (hair loss) and 5mg (BPH) formulations by certified Indian manufacturers, making it a cost-effective alternative to originator brands for global healthcare markets.
GelAdapalene + Benzoyl Peroxide
Adapalene + Benzoyl Peroxide
Synergistic fixed-dose combination gel pairing a third-generation retinoid (adapalene) with a keratolytic antimicrobial (benzoyl peroxide) to simultaneously target comedogenesis and Cutibacterium acnes, delivering superior efficacy over either agent alone for moderate-to-severe acne. This dual-action formulation is widely prescribed globally and produced by certified Indian manufacturers to Galderma-equivalent quality standards.
CreamClobetasol Cream 0.05%
Clobetasol Propionate
Super-potent Class I topical corticosteroid that exerts powerful anti-inflammatory, antipruritic, and vasoconstrictive actions, making it the gold-standard topical therapy for plaque psoriasis, severe eczema, lichen planus, and recalcitrant inflammatory dermatoses. Manufactured to USP/BP standards by leading Indian pharmaceutical companies and exported globally for short-course use under dermatologist supervision.
OintmentMupirocin Ointment 2%
Mupirocin
Topical antibiotic that selectively inhibits bacterial isoleucyl-tRNA synthetase, providing highly effective treatment of impetigo, secondarily infected dermatoses, and nasal MRSA decolonization. Manufactured by certified Indian pharma companies and exported globally for dermatology and hospital infection control applications.
CreamPermethrin Cream 5%
Permethrin
Synthetic pyrethroid that disrupts sodium channel function in ectoparasites, delivering rapid neurotoxic kill against Sarcoptes scabiei and head lice with a single application and excellent residual activity. Widely exported from India in 30g and 60g tube formats for tropical dermatology markets where scabies and pediculosis remain highly prevalent.
LotionCalamine Lotion
Calamine + Zinc Oxide
Classic zinc-calamine lotion that provides rapid antipruritic, drying, and soothing relief for a broad range of pruritic skin conditions including insect bites, chickenpox lesions, sunburn, miliaria, and mild contact dermatitis. An essential OTC dermatological product exported from India in 100ml and 200ml bottle formats for tropical and subtropical healthcare markets worldwide.
CreamKLM GA-6 Glycolic Acid Cream 6%
Glycolic Acid 6%
Dermatologist-recommended alpha hydroxy acid cream from KLM Laboratories that accelerates epidermal cell turnover for smoother, brighter skin. Effectively treats acne scars, melasma, hyperpigmentation, and photoaging with antibacterial and antioxidant properties.
GelKLM Ekran Soft Silicone Sunscreen Gel SPF 50+
Silicone Sunscreen Gel SPF 50+ PA+++
Lightweight silicone-based sunscreen gel from KLM Laboratories offering broad-spectrum UVA/UVB protection with a non-greasy matte finish ideal for Indian and tropical climates. Dermatologist-tested for oily and acne-prone skin types requiring high sun protection.
GelKLM Klin Face Wash
Salicylic Acid 2% + Glycerin 4% + Vitamin E Face Wash
Gentle yet effective daily face wash from KLM Laboratories with salicylic acid for pore unclogging, glycerin for hydration, and vitamin E for antioxidant protection. Specially designed for oily and acne-prone skin to remove excess sebum and impurities without stripping moisture.
CreamKLM Tyrolite Depigmenting Cream
Oligopeptide-68 + Nonapeptide-1 + Rumex Occidentalis Extract
Advanced peptide-based depigmenting cream from KLM Laboratories with three powerful actives — Beta White, Melanostatine, and Tyrostat — that inhibit melanin synthesis without hydroquinone side effects. A safe steroid-free alternative for treating melasma, hyperpigmentation, and uneven skin tone.
LotionKLM Sofidew Moisturizing Lotion
Glycerin + Shea Butter Moisturizer
Dermatologist-formulated daily moisturizing lotion from KLM Laboratories enriched with glycerin, shea butter, and petroleum jelly for deep hydration and skin barrier restoration. Non-comedogenic and fast-absorbing, suitable for dry, sensitive, and eczema-prone skin.
CreamH&H Dermadew Moisturizing Cream
Aloe Vera + Dimethicone Moisturizer
Premium dermatology-grade moisturizing cream from Hegde & Hegde Pharmaceutica featuring aloe vera and dimethicone in a rich emollient base. Trusted by dermatologists across India since 1989 for daily hydration, skin barrier repair, and management of dry, sensitive skin.
CreamH&H Sunban Soft Sunscreen SPF 50+
Broad-Spectrum Sunscreen SPF 50+ PA+++
Widely trusted broad-spectrum sunscreen from Hegde & Hegde Pharmaceutica, India's leading dermatology-focused pharmaceutical company. Lightweight non-greasy texture with superior UVA/UVB protection formulated for daily use in tropical climates.
OintmentH&H Propysalic NF Ointment
Clobetasol 0.05% + Salicylic Acid 3%
Potent combination ointment from Hegde & Hegde Pharmaceutica pairing a super-potent corticosteroid with keratolytic salicylic acid for hyperkeratotic and scaly dermatoses. Salicylic acid enhances clobetasol penetration while removing thick scales, making it particularly effective for psoriasis.
GelH&H Dermadew Acne Face Wash
Salicylic Acid + Tea Tree Oil Face Wash
Dermatologist-recommended anti-acne face wash from Hegde & Hegde Pharmaceutica with salicylic acid for deep pore cleansing and tea tree oil for natural antibacterial action. Controls excess oil, prevents breakouts, and maintains clear skin without over-drying.
OintmentTacrolimus 0.1% Ointment
Tacrolimus
Topical calcineurin inhibitor that blocks T-cell activation and inflammatory cytokine release, offering a steroid-free alternative for managing moderate-to-severe atopic dermatitis on sensitive skin areas including the face and neck. Available in 0.03% (pediatric) and 0.1% (adult) ointments from Indian manufacturers and exported to global dermatology markets as a cost-effective alternative to originator Protopic.
GelBenzoyl Peroxide 5% Gel
Benzoyl Peroxide
Gold-standard topical antimicrobial for acne vulgaris that generates free oxygen radicals to kill Cutibacterium acnes without inducing bacterial resistance, while providing keratolytic and comedolytic activity. Available in multiple strengths from Indian dermatology manufacturers for global export.
CreamAzelaic Acid 20% Cream
Azelaic Acid
Naturally occurring dicarboxylic acid with antimicrobial, anti-inflammatory, and anti-tyrosinase properties, effective for acne vulgaris, rosacea, and post-inflammatory hyperpigmentation without the teratogenicity concerns of retinoids. Manufactured by Cipla and Glenmark for dermatology export markets.
SolutionSalicylic Acid Peel 20%
Salicylic Acid
Beta-hydroxy acid chemical peel solution for professional dermatology use, providing superficial exfoliation effective for comedonal acne, keratosis pilaris, and seborrheic dermatitis. Manufactured by KLM Laboratories and Sun Pharma for dermatology clinic and export markets.
CreamMometasone Cream 0.1%
Mometasone Furoate
Medium-potency topical corticosteroid with once-daily application for inflammatory dermatoses including eczema, psoriasis, and dermatitis. Manufactured by Glenmark and Cipla for dermatology export.
ShampooKetoconazole Shampoo 2%
Ketoconazole
Medicated antifungal shampoo for seborrheic dermatitis and dandruff caused by Malassezia. Manufactured by Cipla and Sun Pharma for dermatology export.
CreamFusidic Acid 2% Cream
Fusidic Acid
Topical antibiotic cream effective against staphylococcal skin infections including impetigo and infected eczema. Manufactured by Glenmark and Cipla for dermatology export.
Anti-Fungal
80 products available
TabletGriseofulvin 250mg
Griseofulvin (Microsize)
Griseofulvin is a fungistatic antibiotic used for dermatophyte infections of the skin, hair, and nails including tinea capitis and onychomycosis. Available in 125mg, 250mg, and 500mg strengths for global pharmaceutical export.
CreamClotrimazole Cream 1%
Clotrimazole
Clotrimazole 1% cream is a broad-spectrum imidazole antifungal for dermatophyte, yeast, and Candida skin infections including athlete's foot, ringworm, and pityriasis versicolor. Available in 30g tubes for global pharmaceutical export.
TabletFluconazole 150mg
Fluconazole
Fluconazole is a triazole antifungal used for candidiasis, cryptococcal meningitis, and systemic fungal infections. Available in 50mg, 100mg, 150mg, and 200mg strengths for global pharmaceutical export.
CapsuleItraconazole 200mg
Itraconazole
Broad-spectrum lipophilic triazole antifungal with activity against dermatophytes, yeasts, and molds including Aspergillus and endemic dimorphic fungi, widely used for onychomycosis, histoplasmosis, aspergillosis, and systemic candidiasis. Manufactured in pellet-filled capsules by leading Indian pharmaceutical companies and exported for use in tropical infectious disease and dermatology settings globally.
TabletTerbinafine 250mg
Terbinafine Hydrochloride
Allylamine antifungal with fungicidal activity against dermatophytes through selective inhibition of squalene epoxidase, resulting in lethal accumulation of squalene within fungal cells and highly effective nail penetration for onychomycosis treatment. Preferred oral agent for tinea and nail fungal infections due to shorter treatment courses compared to older antifungals; widely exported from India in 250mg tablets.
TabletVoriconazole 200mg
Voriconazole
Second-generation triazole antifungal that is the primary treatment of choice for invasive aspergillosis, offering broader coverage against Fusarium, Scedosporium, and azole-susceptible Candida species compared to fluconazole. Manufactured and exported by leading Indian generic companies including Cipla and Natco as a cost-effective alternative for life-threatening fungal infections in immunocompromised and oncology patients.
CreamKetoconazole 2% Cream
Ketoconazole
Topical imidazole antifungal cream with potent activity against dermatophytes, Malassezia, and Candida species by inhibiting ergosterol synthesis and disrupting fungal cell membrane permeability. Preferred topical choice for seborrheic dermatitis, pityriasis versicolor, and tinea infections, widely exported from India in 30g tubes for dermatology practices and pharmacy retail channels globally.
InjectionAmphotericin B 50mg
Amphotericin B
Gold-standard polyene antifungal injection with broad-spectrum fungicidal activity against invasive aspergillosis, cryptococcal meningitis, mucormycosis, systemic candidiasis, and visceral leishmaniasis. Manufactured as lyophilized powder for IV infusion and exported for hospital formularies managing severe fungal infections in immunocompromised and critically ill patients.
TabletPosaconazole 100mg
Posaconazole
Extended-spectrum triazole antifungal with superior activity against mucormycosis and aspergillosis compared to other azoles, increasingly preferred as first-line therapy for mucormycosis and prophylaxis in severely immunocompromised patients. Manufactured by Cipla and Natco as delayed-release tablets for oncology and transplant formulary export.
InjectionCaspofungin 50mg Injection
Caspofungin Acetate
First-in-class echinocandin antifungal that inhibits beta-1,3-D-glucan synthesis in fungal cell walls, providing fungicidal activity against Candida species and fungistatic activity against Aspergillus without cross-resistance to azoles or polyenes. Manufactured by Cipla and Glenmark for hospital ICU formulary export.
InjectionMicafungin 100mg Injection
Micafungin Sodium
Second-generation echinocandin antifungal with linear pharmacokinetics and no need for loading dose, approved for treatment of candidemia, esophageal candidiasis, and prophylaxis of Candida infections in stem cell transplant recipients. Manufactured by Cipla and Sun Pharma for hospital and transplant program export markets.
InjectionAnidulafungin 100mg Injection
Anidulafungin
Third echinocandin antifungal with non-hepatic degradation, making it suitable for patients with hepatic impairment. Manufactured by Cipla for hospital ICU export.
SuspensionNystatin Oral Suspension
Nystatin
Polyene antifungal for topical treatment of oral and intestinal candidiasis without systemic absorption. Manufactured by Sun Pharma and Cipla for global export.
CapsuleFlucytosine 500mg
Flucytosine
Fluorinated pyrimidine antifungal used in combination with amphotericin B for cryptococcal meningitis. Manufactured by Cipla for hospital infectious disease export.
CapsuleIsavuconazole 100mg
Isavuconazonium Sulfate
Latest-generation triazole antifungal with broad-spectrum activity against Aspergillus and Mucorales species with fewer drug interactions than voriconazole. Manufactured by Cipla for oncology export.
Steroids & Hormonal
57 products available
GelTestosterone Gel 1%
Testosterone
Transdermal testosterone replacement therapy delivering consistent physiological testosterone levels through daily skin application, designed for men with primary or secondary hypogonadism requiring a convenient and non-invasive hormone replacement option. Packaged in pre-measured 5g sachets for precise 50mg dosing and exported from India in 30-sachet boxes to international men's health and hormone therapy markets.
InjectionTestosterone Enanthate 250mg
Testosterone Enanthate
Long-acting testosterone ester in oil providing sustained serum testosterone levels lasting 2-4 weeks per injection, making it the most widely used injectable TRT formulation for male hypogonadism, delayed puberty, and gender-affirming hormone therapy. Manufactured to GMP standards by Zydus Cadila and exported in single-dose ampoules for urology, endocrinology, and men's health clinics worldwide.
TabletAnastrozole 1mg
Anastrozole
Potent non-steroidal aromatase inhibitor that selectively blocks estrogen biosynthesis by >99% in postmenopausal women, making it the first-line adjuvant therapy for hormone receptor-positive breast cancer and a key component of testosterone replacement protocols to control estrogen conversion. Manufactured by leading Indian oncology companies and exported globally as a cost-effective alternative to Arimidex for both oncology and men's health indications.
TabletClomiphene 50mg
Clomiphene Citrate
Selective estrogen receptor modulator (SERM) that blocks hypothalamic estrogen receptors to stimulate gonadotropin release and trigger ovulation in anovulatory women, and secondarily raises endogenous testosterone in hypogonadal men. A well-established, cost-effective fertility and hormone therapy agent manufactured by Sun Pharma and Cipla and exported globally for reproductive endocrinology practices.
InjectionHCG 5000 IU
Human Chorionic Gonadotropin
LH-mimicking gonadotropin that triggers final follicular maturation and ovulation in IVF protocols, and stimulates endogenous testosterone production in hypogonadal men and boys with cryptorchidism. Supplied by Bharat Serums and Sun Pharma as lyophilized powder with solvent, exported in multiple potencies for reproductive endocrinology and urology practices worldwide.
TabletCabergoline 0.5mg
Cabergoline
Long-acting ergot-derived dopamine D2 agonist that normalizes serum prolactin and reduces prolactinoma size with twice-weekly dosing, offering superior tolerability over older dopamine agonists. Exported by Sun Pharma and Cipla for endocrinology and neurology markets in applications covering hyperprolactinemia, lactation inhibition, and adjunct Parkinson's therapy.
TabletPrednisolone 20mg
Prednisolone
Synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties used as a versatile oral corticosteroid for asthma, autoimmune diseases, inflammatory bowel disease, and organ transplant maintenance. Available from Cipla and Sun Pharma in a range of tablet strengths for flexible dosing, exported globally as an affordable first-choice corticosteroid for acute and chronic inflammatory conditions.
InjectionSustanon 250mg Injection
Testosterone Blend
Proprietary four-ester testosterone blend (propionate, phenylpropionate, isocaproate, decanoate) designed to provide both rapid onset and prolonged testosterone release in a single injection, offering stable serum levels with once monthly or bi-weekly dosing. Manufactured by Organon and Zydus Cadila and exported globally for TRT, delayed puberty, and gender-affirming hormone therapy under endocrinologist supervision.
TabletMifepristone + Misoprostol Kit
Mifepristone + Misoprostol
WHO-recommended two-drug MTP regimen combining mifepristone (antiprogestogen) with misoprostol (prostaglandin) for safe, effective non-surgical pregnancy termination up to 9 weeks gestation with efficacy exceeding 95%. Prescription-only kit manufactured by Cipla and Sun Pharma and exported to global reproductive health programs and regulated pharmacy channels.
TabletLetrozole + Folic Acid
Letrozole + Folic Acid
Combination of aromatase inhibitor with folic acid for ovulation induction in PCOS, increasingly preferred over clomiphene. Manufactured by Sun Pharma for reproductive endocrinology export.
CapsuleProgesterone 200mg
Natural Micronized Progesterone
Bioidentical micronized progesterone for luteal phase support in IVF cycles and hormone replacement therapy. Manufactured by Sun Pharma and Cipla for reproductive health export.
TabletDydrogesterone 10mg
Dydrogesterone
Retroprogesterone with selective progestogenic activity and no androgenic, estrogenic, or glucocorticoid effects, used for threatened miscarriage and endometriosis. Manufactured by Sun Pharma for export.
TabletTamoxifen 20mg
Tamoxifen Citrate
SERM used as adjuvant therapy for hormone receptor-positive breast cancer in premenopausal women and for prevention in high-risk individuals. Manufactured by Cipla and Sun Pharma for oncology export.
Cardiac & Anti-Coagulant
75 products available
TabletMetoprolol Succinate 50mg
Metoprolol Succinate
Cardioselective beta-1 adrenoceptor blocker in extended-release formulation that reduces heart rate, blood pressure, and myocardial oxygen demand with once-daily dosing for hypertension, stable angina, and heart failure with reduced ejection fraction. Manufactured to USP standards by Sun Pharma and Cipla and exported globally as a key cardiovascular agent in hypertension, post-MI, and heart failure management protocols.
TabletLosartan 50mg
Losartan Potassium
Selective AT1 angiotensin II receptor blocker (ARB) that reduces blood pressure, protects renal function in diabetic nephropathy, and decreases cardiovascular events in hypertensive patients with left ventricular hypertrophy, with a tolerability advantage over ACE inhibitors due to the absence of bradykinin-mediated cough. Manufactured by Cipla and Sun Pharma and exported globally as a widely-used first-line antihypertensive and renoprotective agent.
TabletRamipril 5mg
Ramipril
Long-acting ACE inhibitor with demonstrated cardiovascular risk reduction benefits across hypertension, post-MI left ventricular dysfunction, chronic heart failure, and diabetic nephropathy, supported by landmark HOPE and REIN trial data. Available in four strengths from Sanofi and Cipla for stepwise titration, exported globally as a cornerstone RAAS agent in both primary and secondary cardiovascular prevention protocols.
TabletWarfarin 5mg
Warfarin Sodium
Vitamin K antagonist oral anticoagulant that prevents thromboembolic events by inhibiting hepatic synthesis of clotting factors II, VII, IX, and X, remaining the standard of care for mechanical heart valves and widely used in atrial fibrillation and VTE treatment worldwide. Supplied in multiple low-dose strengths from Sun Pharma and Cipla to allow fine INR titration, exported for anticoagulation clinics and hospital cardiology departments globally.
TabletRivaroxaban 20mg
Rivaroxaban
Direct oral factor Xa inhibitor (DOAC) that provides predictable anticoagulation without routine INR monitoring, approved for stroke prevention in non-valvular atrial fibrillation, treatment and secondary prevention of DVT/PE, and VTE prophylaxis after major orthopaedic surgery. Manufactured by Cipla and Natco as a cost-effective generic alternative to Xarelto, exported for cardiology and thrombosis management programs in emerging healthcare markets.
TabletAtorvastatin 40mg
Atorvastatin Calcium
High-efficacy HMG-CoA reductase inhibitor delivering the greatest LDL cholesterol reduction per milligram among available statins, making it the most prescribed cardiovascular lipid-lowering agent globally for primary and secondary prevention of major cardiac events. Available in four potency levels from Cipla and Sun Pharma and exported as a highly affordable generic to Lipitor for dyslipidemia management across all cardiovascular risk categories.
TabletClopidogrel 75mg
Clopidogrel Bisulfate
Irreversible P2Y12 ADP receptor antagonist that inhibits platelet aggregation and is essential dual antiplatelet therapy with aspirin for ACS and coronary stent placement, as well as secondary prevention of MI, stroke, and peripheral arterial disease events. Manufactured by Sun Pharma and Cipla and exported globally as an indispensable generic to Plavix for interventional cardiology and secondary cardiovascular prevention programs.
TabletAmlodipine 10mg
Amlodipine Besylate
Long-acting dihydropyridine calcium channel blocker with a 35-40 hour half-life providing smooth, sustained blood pressure reduction and coronary vasodilation with once-daily dosing. A pillar antihypertensive agent manufactured by Cipla and Sun Pharma in three strengths and exported globally for hypertension, stable angina, and vasospastic angina management in primary care and cardiology settings.
TabletRosuvastatin 20mg
Rosuvastatin Calcium
Hydrophilic, high-potency HMG-CoA reductase inhibitor delivering superior LDL reduction at lower doses than lipophilic statins, with proven benefit in primary cardiovascular prevention demonstrated in the JUPITER trial. Manufactured in four strengths by Cipla and Sun Pharma and exported globally as an affordable generic to Crestor for aggressive dyslipidemia management, atherosclerosis regression, and cardiovascular risk reduction.
TabletTelmisartan 80mg
Telmisartan
Longest-acting ARB with a 24-hour half-life providing smooth round-the-clock blood pressure control via once-daily dosing, with additional partial PPARgamma agonist activity conferring metabolic benefits. Manufactured by Cipla and Glenmark in three strengths and exported globally for hypertension and cardiovascular risk reduction, particularly in ACE inhibitor-intolerant patients.
TabletSacubitril + Valsartan 50mg
Sacubitril + Valsartan
First-in-class ARNI combining neprilysin inhibitor with ARB for heart failure with reduced ejection fraction, shown superior to enalapril in the PARADIGM-HF trial. Manufactured by Natco and Cipla for cardiology export.
TabletApixaban 5mg
Apixaban
Direct oral factor Xa inhibitor with superior safety profile over warfarin, approved for stroke prevention in AF and DVT/PE treatment. Manufactured by Natco and Cipla for cardiology export.
TabletIvabradine 5mg
Ivabradine Hydrochloride
Selective If channel inhibitor that reduces heart rate without affecting blood pressure or myocardial contractility, used in stable angina and heart failure. Manufactured by Cipla and Sun Pharma for cardiology export.
CapsuleDabigatran 150mg
Dabigatran Etexilate
Direct thrombin inhibitor DOAC for stroke prevention in AF with the advantage of having a specific reversal agent (idarucizumab). Manufactured by Cipla and Natco for export.
Antiparasitic
55 products available
TabletMebendazole 100mg
Mebendazole
Broad-spectrum benzimidazole anthelmintic that selectively inhibits tubulin polymerization in parasitic worms, disrupting glucose uptake and leading to helminth immobilization without significant systemic drug absorption. Available as chewable tablets from Cipla and Mankind Pharma, exported as a first-line WHO-essential medicine for mass deworming programs and clinical management of intestinal nematode infections.
TabletPraziquantel 600mg
Praziquantel
WHO-essential anthelmintic that causes tegumental disruption and spastic paralysis in susceptible flatworms and tapeworms, making it the cornerstone treatment for schistosomiasis, neurocysticercosis, and biliary fluke infections. Manufactured by Sun Pharma and Cipla and exported for tropical and neglected disease programs across sub-Saharan Africa, Southeast Asia, and Latin America where parasitic infections remain highly prevalent.
TabletIvermectin 12mg
Ivermectin
Macrocyclic lactone antiparasitic that hyperpolarizes invertebrate nerve and muscle membranes by potentiating glutamate-gated chloride channels, causing paralysis and death of susceptible nematodes and ectoparasites. A WHO-essential medicine manufactured by Sun Pharma and Cipla in multiple strengths, exported for mass drug administration programs targeting onchocerciasis, lymphatic filariasis, and scabies in endemic tropical regions.
TabletAlbendazole 400mg
Albendazole
Broad-spectrum benzimidazole anthelmintic with systemic bioavailability for treating tissue larval stages, hydatid cysts, and neurocysticercosis in addition to intestinal nematodes. A WHO-essential medicine manufactured by GSK and Cipla and exported for single-dose intestinal deworming programs and extended-course systemic parasitic disease treatment worldwide.
TabletFenbendazole 222mg
Fenbendazole
Benzimidazole anthelmintic widely used in veterinary medicine for treatment of roundworm, hookworm, whipworm, and tapeworm infections in companion and livestock animals, with growing investigational interest in human applications due to its microtubule-disrupting mechanism. Supplied by Indian manufacturers in 222mg tablets and exported for veterinary pharmacy channels and research-use procurement.
TabletHydroxychloroquine 200mg
Hydroxychloroquine Sulfate
Aminoquinoline antimalarial and disease-modifying antirheumatic drug (DMARD) that interferes with lysosomal function and immune activation, providing effective prophylaxis and treatment of malaria alongside long-term management of rheumatoid arthritis and systemic lupus erythematosus. Manufactured by Ipca Labs and Cipla as a WHO-essential medicine and exported globally for rheumatology, tropical medicine, and preventive malaria programs.
TabletNitazoxanide 500mg
Nitazoxanide
Thiazolide antiprotozoal agent that inhibits pyruvate:ferredoxin oxidoreductase (PFOR) enzyme activity in anaerobic protozoa, providing effective 3-day oral treatment for diarrhea caused by Cryptosporidium parvum and Giardia lamblia with demonstrated pediatric and adult dosing. Manufactured by Cipla and Lupin and exported for gastrointestinal infection management in tropical and developing-world healthcare settings where waterborne parasitic infections are prevalent.
TabletNiclosamide 500mg
Niclosamide
Salicylanilide anthelmintic that uncouples oxidative phosphorylation in cestode mitochondria for treatment of tapeworm infections. Manufactured by Cipla for tropical medicine export.
TabletDiethylcarbamazine 100mg
Diethylcarbamazine Citrate
Piperazine derivative used in mass drug administration for lymphatic filariasis elimination. Manufactured by Cipla and Mankind for tropical medicine export.
General Health
89 products available
TabletCetirizine 10mg
Cetirizine Hydrochloride
Second-generation piperazine H1-antihistamine with low CNS penetration, providing effective once-daily relief from allergic rhinitis, chronic idiopathic urticaria, and allergic conjunctivitis with minimal sedation compared to older antihistamines. Available in 5mg and 10mg strengths from Cipla and Mankind Pharma and widely exported as a cost-effective staple antiallergic for pharmacy, hospital, and community health markets globally.
TabletLevocetirizine 5mg
Levocetirizine Dihydrochloride
Pharmacologically active R-enantiomer of cetirizine with approximately twice the H1-receptor binding affinity, delivering potent antihistamine efficacy at lower doses with an excellent tolerability profile suitable for once-evening dosing. Manufactured by Sun Pharma and Torrent in tablet and syrup forms and exported globally as a preferred second-generation antihistamine for allergic rhinitis, chronic urticaria, and atopic conditions.
TabletMetformin 1000mg
Metformin Hydrochloride
First-line biguanide antidiabetic that reduces hepatic gluconeogenesis and improves peripheral insulin sensitivity without causing hypoglycemia or weight gain, making it the WHO-essential global standard-of-care for newly diagnosed type 2 diabetes. Available from USV and Cipla in three dose strengths for stepwise titration and exported worldwide as the most cost-effective oral antidiabetic with robust cardiovascular safety evidence.
TabletPantoprazole 40mg
Pantoprazole Sodium
Benzimidazole proton pump inhibitor that irreversibly blocks H+/K+-ATPase in gastric parietal cells, providing potent and sustained acid suppression for treatment of GERD, erosive esophagitis, peptic ulcers, and Zollinger-Ellison syndrome with fewer drug interactions than omeprazole. Manufactured in enteric-coated tablets by Cipla and Sun Pharma and exported globally as a preferred PPI for hospital and community pharmacy formularies.
TabletModafinil 200mg
Modafinil
Novel wakefulness-promoting agent with a mechanism distinct from amphetamines, selectively activating wake-promoting brain circuits to treat excessive daytime sleepiness in narcolepsy, shift work disorder, and sleep apnea with a lower abuse potential. Manufactured by Sun Pharma and HAB Pharma and exported as a high-demand cognitive performance and sleep disorder drug for neurology and occupational health markets globally.
CapsuleOrlistat 120mg
Orlistat
Gastrointestinal lipase inhibitor that prevents approximately 30% of dietary fat absorption by forming covalent bonds with pancreatic and gastric lipase, facilitating modest but clinically meaningful weight loss as an adjunct to calorie restriction in obese patients. Manufactured by Cipla and Intas in 60mg (OTC) and 120mg (prescription) capsules and exported for obesity management programs in primary care and specialist weight management clinics worldwide.
TabletClenbuterol 40mcg
Clenbuterol Hydrochloride
Selective beta-2 adrenergic agonist with bronchodilatory properties approved for respiratory indications in some countries, with widely documented off-label use for thermogenic fat loss and lean muscle preservation in bodybuilding and athletic contexts. Available from Indian manufacturers in multiple microgram strengths and exported for markets where the compound is legally prescribed or supplied for non-human research and veterinary applications.
InjectionSomatropin (HGH) Injection
Somatropin
Recombinant DNA-derived somatropin identical to endogenous human growth hormone, stimulating linear growth, protein synthesis, lipolysis, and IGF-1 production for treatment of pediatric growth failure, Turner syndrome, and adult GH deficiency states. Available as lyophilized vials and pre-filled injection pens from LG Lifesciences and Cipla, exported for pediatric endocrinology, HIV-wasting, and specialized metabolic disorder programs.
SyrupPromethazine Syrup
Promethazine Hydrochloride
Phenothiazine-class first-generation antihistamine with additional antiemetic, anticholinergic, and sedative properties, providing versatile symptomatic relief for allergic conditions, motion sickness, postoperative nausea, and premedication sedation. Available as a pleasantly flavored 100ml syrup from Cipla and Sun Pharma, exported for pediatric allergy and hospital formulary use where multiple antiemetic and antihistamine indications are required.
TabletUrsodeoxycholic Acid 300mg
Ursodeoxycholic Acid (UDCA)
Hydrophilic bile acid for dissolution of cholesterol gallstones and treatment of primary biliary cholangitis. Manufactured by Sun Pharma and Cipla for hepato-gastroenterology export.
TabletDiosmin 500mg
Diosmin
Flavonoid venoactive drug that improves venous tone, lymphatic drainage, and microcirculation for treatment of chronic venous insufficiency and hemorrhoids. Manufactured by Sun Pharma and Torrent for vascular export.
TabletTrimebutine 200mg
Trimebutine Maleate
Antispasmodic acting on peripheral enkephalin receptors to regulate GI motility for IBS and functional GI disorders. Manufactured by Sun Pharma and Torrent for gastroenterology export.
TabletRebamipide 100mg
Rebamipide
Mucosal protective agent that stimulates prostaglandin synthesis and mucus secretion for gastric ulcer healing and NSAID gastroprotection. Manufactured by Zydus and Mankind for export.
Weight Loss & GLP-1 Agonists
45 products available
InjectionRetatrutide Injection
Retatrutide
Investigational triple incretin receptor agonist (GIP/GLP-1/Glucagon) demonstrating exceptional weight loss exceeding 24% body weight in Phase 2 trials, surpassing all currently approved anti-obesity medications and representing the next generation of metabolic therapies. Supplied by Indian manufacturers for research procurement and supplied to markets where investigational compounds are accessible under physician oversight.
InjectionTirzepatide Injection
Tirzepatide
First-in-class dual GIP/GLP-1 receptor agonist (twincretin) demonstrating superior HbA1c reduction and up to 22.5% body weight loss in SURPASS and SURMOUNT trials, outperforming semaglutide across all dose levels in head-to-head studies. Available in six escalating weekly dose strengths as a single-dose auto-injector pen, supplied by Eli Lilly-aligned and Indian generic manufacturers for diabetes and obesity management globally.
TabletSemaglutide Tablets
Semaglutide
World's first oral GLP-1 receptor agonist (Rybelsus) utilizing SNAC absorption technology to enable gastrointestinal uptake of this large peptide molecule, providing once-daily tablet convenience for type 2 diabetes management with HbA1c reductions comparable to injectable GLP-1 agonists. Supplied in 30-tablet bottles from Novo Nordisk-aligned and Indian manufacturers and exported for diabetes management programs preferring non-injectable therapy.
InjectionSemaglutide Injection
Semaglutide
Long-acting GLP-1 receptor agonist with a 168-hour half-life enabling once-weekly subcutaneous dosing for type 2 diabetes (Ozempic, up to 2mg) and chronic weight management (Wegovy, 2.4mg), with proven cardiovascular risk reduction in the SUSTAIN and STEP trial programs. Available as a pre-filled pen from Novo Nordisk-aligned and Indian generic manufacturers and exported globally as one of the most prescribed GLP-1 agents for diabetes and obesity.
InjectionLiraglutide Injection
Liraglutide
Pioneer once-daily GLP-1 receptor agonist with a 13-hour half-life, approved both as Victoza (1.2-1.8mg for type 2 diabetes) and Saxenda (3.0mg for chronic weight management), with landmark LEADER trial data demonstrating significant cardiovascular mortality reduction. Supplied in 3ml pre-filled pens by Novo Nordisk-aligned and Indian manufacturers and exported globally for endocrinology and specialized weight management clinics.
TabletNaltrexone + Bupropion 8/90mg
Naltrexone + Bupropion
Dual-mechanism anti-obesity combination targeting hypothalamic appetite regulation via opioid antagonist and dopamine/norepinephrine reuptake inhibition. Manufactured by Sun Pharma for weight management export.
TabletAcarbose 50mg
Acarbose
Alpha-glucosidase inhibitor that delays carbohydrate digestion and reduces postprandial glucose spikes, useful as adjunct therapy in type 2 diabetes and modest weight management. Manufactured by Bayer and Torrent for export.
Phentermine 37.5mg
Phentermine Hydrochloride
Sympathomimetic amine appetite suppressant for short-term obesity management as adjunct to caloric restriction. Manufactured by Indian pharmaceutical companies for controlled markets export.
Eye & Ear Drops
63 products available
DropsOfloxacin Eye Drops 0.3%
Ofloxacin
Fourth-generation fluoroquinolone ophthalmic solution with broad-spectrum bactericidal activity against both gram-positive and gram-negative ocular pathogens. Widely prescribed for bacterial conjunctivitis, corneal ulcers, and post-surgical prophylaxis owing to excellent penetration into ocular tissues and a proven safety record.
DropsTobramycin Eye Drops 0.3%
Tobramycin
Aminoglycoside antibiotic ophthalmic solution with potent bactericidal activity, particularly effective against Pseudomonas aeruginosa and other gram-negative organisms responsible for severe ocular infections. Frequently used in combination with corticosteroids for inflammatory bacterial conditions of the anterior segment.
Eye DropBimatoprost Eye Drops 0.03%
Bimatoprost
Synthetic prostamide analog that lowers intraocular pressure by increasing uveoscleral outflow, offering superior IOP reduction compared to beta-blockers as first-line glaucoma therapy. Also licensed for cosmetic eyelash enhancement (hypotrichosis) under the Latisse/Careprost brand, reflecting dual therapeutic utility.
Eye DropCareprost Eye Drops
Bimatoprost
India's best-known bimatoprost ophthalmic solution, manufactured by Sun Pharma, widely exported for both open-angle glaucoma management and cosmetic eyelash growth. Delivers clinically proven IOP reduction with once-nightly dosing, making it a leading export product in the ophthalmic segment.
Eye DropMoxifloxacin Eye Drops 0.5%
Moxifloxacin
Preservative-free fourth-generation fluoroquinolone ophthalmic solution with self-preserved formulation, offering superior gram-positive coverage including MRSA over earlier fluoroquinolones. Preferred agent for post-cataract surgery prophylaxis and treatment of bacterial keratitis across international markets.
Eye DropLatanoprost Eye Drops 0.005%
Latanoprost
First prostaglandin analog approved for glaucoma, reducing intraocular pressure by 25-35% through enhanced uveoscleral aqueous humor outflow with once-daily evening dosing. Considered a gold-standard first-line agent for open-angle glaucoma in global ophthalmology guidelines.
Eye DropTimolol Eye Drops 0.5%
Timolol Maleate
Non-selective beta-adrenergic blocking ophthalmic solution that reduces aqueous humor production, representing one of the longest-established and most cost-effective glaucoma therapies globally. Available in both standard and once-daily gel-forming (Timoptic-XE) formulations for sustained IOP control.
Eye DropDorzolamide + Timolol Eye Drops
Dorzolamide + Timolol
Fixed-dose combination of a carbonic anhydrase inhibitor (dorzolamide) and a beta-blocker (timolol) that simultaneously reduces aqueous humor production via two complementary mechanisms, providing additive IOP lowering superior to either agent alone. Simplifies treatment regimen for patients requiring dual glaucoma therapy.
DropsBrimonidine Tartrate Eye Drops 0.2%
Brimonidine Tartrate
Selective alpha-2 adrenergic agonist eye drops that reduce aqueous humor production and increase uveoscleral outflow, providing effective intraocular pressure reduction in open-angle glaucoma. Well tolerated with minimal systemic absorption and suitable for long-term use as monotherapy or adjunct therapy.
DropsNepafenac Ophthalmic Suspension 0.1%
Nepafenac
Topical NSAID prodrug that penetrates the cornea and is converted to amfenac, a potent cyclooxygenase inhibitor, within ocular tissues. Provides targeted anti-inflammatory action for post-cataract surgery pain and inflammation with superior intraocular bioavailability.
DropsFluorometholone Eye Drops 0.1%
Fluorometholone
Mild-potency ophthalmic corticosteroid with lower intraocular pressure elevation risk compared to dexamethasone and prednisolone, making it preferred for treating superficial ocular inflammation. Effective for allergic conjunctivitis, episcleritis, and post-operative inflammation with reduced steroid-related complications.
Eye DropOlopatadine Eye Drops 0.1%
Olopatadine Hydrochloride
Dual-action antihistamine and mast cell stabilizer ophthalmic solution for allergic conjunctivitis. Manufactured by Sun Pharma and Cipla for ophthalmology export.
Ear DropCiprofloxacin + Dexamethasone Ear Drops
Ciprofloxacin + Dexamethasone
Antibiotic-corticosteroid combination ear drops for otitis externa and otitis media with tympanostomy tubes. Manufactured by Sun Pharma for ENT export.
Eye DropTravoprost Eye Drops 0.004%
Travoprost
Prostaglandin F2-alpha analog that lowers IOP by increasing uveoscleral outflow for open-angle glaucoma treatment. Manufactured by Sun Pharma and Cipla for ophthalmology export.
Pain Management
59 products available
TabletNaproxen 500mg
Naproxen Sodium
Propionic acid NSAID with a 12-hour half-life enabling convenient twice-daily dosing for chronic arthritis and acute pain conditions. Preferred over ibuprofen in primary dysmenorrhea and acute gouty arthritis for its sustained anti-inflammatory action, widely exported from India owing to an excellent cost-to-efficacy ratio.
TabletEtoricoxib 90mg
Etoricoxib
Highly selective COX-2 inhibitor delivering potent anti-inflammatory and analgesic efficacy with a significantly reduced gastrointestinal adverse event profile versus non-selective NSAIDs. Once-daily dosing across indications from osteoarthritis maintenance to acute gout flares makes it a preferred choice in high-volume pharmaceutical export markets.
TabletParacetamol 500mg
Paracetamol (Acetaminophen)
World's most widely used analgesic and antipyretic, recommended as first-line therapy for mild-to-moderate pain by WHO and international clinical guidelines owing to its safety at therapeutic doses and lack of GI or cardiovascular risks. Available in multiple strengths and formulations, with India being one of the largest global manufacturers and exporters.
TabletDiclofenac Sodium 50mg
Diclofenac Sodium
One of the most widely prescribed NSAIDs globally, with phenylacetic acid structure offering potent COX inhibition for pain relief and anti-inflammatory action across a broad range of acute and chronic conditions. Available as immediate-release, sustained-release, and injectable formulations, making it a versatile backbone of pain management formularies worldwide.
TabletAceclofenac + Paracetamol
Aceclofenac + Paracetamol
Fixed-dose combination pairing the selective COX-2-preferring NSAID aceclofenac with paracetamol for complementary analgesic mechanisms — peripheral anti-inflammatory action combined with central analgesia. Widely prescribed in India, Southeast Asia, and Africa for musculoskeletal pain with a better GI tolerability profile than diclofenac.
CapsulePregabalin + Methylcobalamin
Pregabalin + Methylcobalamin
Rational fixed-dose combination pairing pregabalin's voltage-gated calcium channel modulation for neuropathic pain relief with methylcobalamin's nerve remyelination and regeneration properties. Addresses both symptomatic and underlying pathological aspects of diabetic peripheral neuropathy, postherpetic neuralgia, and B12-deficient peripheral neuropathy in a single capsule.
Tapentadol 100mg
Tapentadol Hydrochloride
Dual-mechanism analgesic combining mu-opioid agonism with norepinephrine reuptake inhibition for moderate-to-severe pain management. Manufactured by Sun Pharma and Torrent for export.
Tramadol + Paracetamol 37.5/325mg
Tramadol + Paracetamol
Fixed-dose combination providing complementary analgesic mechanisms via weak opioid agonism and central antipyretic action for moderate pain. Manufactured by Cipla and Mankind for export.
CapsuleFlupirtine 100mg
Flupirtine Maleate
Non-opioid central analgesic acting via selective neuronal potassium channel opening with muscle relaxant properties. Manufactured by Lupin for short-term pain management export.
CapsuleCelecoxib 200mg
Celecoxib
Selective COX-2 inhibitor providing anti-inflammatory analgesia with significantly lower GI ulceration risk compared to non-selective NSAIDs. Manufactured by Cipla and Dr. Reddy's for export.
Diabetes & Metabolic
120 products available
TabletGlimepiride 2mg
Glimepiride
Third-generation sulfonylurea that stimulates pancreatic beta-cell insulin secretion via selective SUR1 receptor binding, offering a lower hypoglycemia risk compared to earlier sulfonylureas due to glucose-dependent activity. The most cost-effective oral antidiabetic agent in its class and a cornerstone of type 2 diabetes management in emerging markets.
TabletSitagliptin 100mg
Sitagliptin Phosphate
First-in-class DPP-4 inhibitor that amplifies incretin-mediated glucose-dependent insulin secretion while suppressing glucagon, offering glycemic control without weight gain or intrinsic hypoglycemia risk. Once-daily dosing, renal dose adjustment flexibility, and a decade-long cardiovascular safety record make it a globally preferred add-on antidiabetic.
TabletVildagliptin 50mg
Vildagliptin
Selective DPP-4 inhibitor with potent enzyme inhibition that improves glycemic control through enhanced incretin-mediated insulin secretion and suppressed post-meal glucagon release. Widely prescribed as a fixed-dose combination with metformin (Galvusmet) offering convenient dual-mechanism therapy without weight gain.
TabletPioglitazone 30mg
Pioglitazone Hydrochloride
PPAR-gamma agonist thiazolidinedione that improves insulin sensitivity in peripheral tissues — muscle, fat, and liver — and favorably modifies lipid profiles by increasing HDL and reducing triglycerides. Uniquely addresses the underlying insulin resistance pathophysiology of type 2 diabetes and is widely used in combination regimens across Asia and Africa.
TabletGliclazide MR 80mg
Gliclazide
Second-generation sulfonylurea with a modified-release formulation providing smooth, sustained insulin secretion throughout the day with minimal hypoglycemia risk due to its glucose-dependent mechanism and antioxidant properties. Demonstrated cardioprotective and renal-protective properties in clinical studies, making it the preferred sulfonylurea in high-risk cardiovascular patients.
TabletEmpagliflozin 10mg
Empagliflozin
SGLT-2 inhibitor that reduces cardiovascular death by 38% and heart failure hospitalization by 35% in T2DM patients with established cardiovascular disease (EMPA-REG OUTCOME trial), the first antidiabetic drug to demonstrate such landmark mortality benefit. Approved for heart failure regardless of diabetes status, establishing a new paradigm in cardiometabolic medicine.
TabletDapagliflozin 10mg
Dapagliflozin Propanediol
Broad-spectrum SGLT-2 inhibitor with triple regulatory approvals for type 2 diabetes, heart failure with reduced ejection fraction, and chronic kidney disease — the widest indication set in its class. DAPA-HF and DAPA-CKD trials demonstrated transformational reductions in CKD progression and HF hospitalization independent of diabetes status.
InjectionInsulin Glargine 100 IU/mL
Insulin Glargine
Recombinant long-acting basal insulin analog engineered for a peakless, 24-hour action profile through subcutaneous microprecipitate formation, enabling consistent once-daily dosing without the pronounced peak-related hypoglycemia seen with NPH insulin. Sanofi Lantus biosimilars from Biocon and other Indian manufacturers have significantly expanded access in emerging markets.
TabletVoglibose 0.3mg
Voglibose
Alpha-glucosidase inhibitor that delays carbohydrate digestion to specifically control post-prandial hyperglycemia without significant systemic drug exposure. Uniquely approved in India for delaying onset of type 2 diabetes in patients with impaired glucose tolerance, adding a preventive dimension beyond standard glycemic management.
TabletTeneligliptin 20mg
Teneligliptin Hydrobromide Hydrate
Novel DPP-4 inhibitor with a unique thiazolidine-based structure providing prolonged enzyme inhibition, approved in India, Japan, and South Korea for type 2 diabetes management. A more affordable alternative to patent-protected DPP-4 inhibitors, it has gained significant market share in Asia and emerging markets with an established safety profile.
TabletGlimepiride + Metformin 2/500mg
Glimepiride + Metformin
Fixed-dose combination of sulfonylurea and biguanide for dual-mechanism glycemic control when monotherapy is inadequate. Manufactured by USV and Cipla for diabetes export.
TabletEmpagliflozin 25mg
Empagliflozin
SGLT2 inhibitor with proven cardiovascular mortality benefit in the EMPA-REG OUTCOME trial for T2DM patients with CVD. Manufactured by Cipla and Glenmark for export.
TabletLinagliptin 5mg
Linagliptin
DPP-4 inhibitor unique for its non-renal elimination, requiring no dose adjustment in any degree of renal impairment. Manufactured by Cipla and Glenmark for diabetology export.
TabletCanagliflozin 300mg
Canagliflozin
First SGLT2 inhibitor approved with cardiovascular and renal outcome benefits in the CANVAS and CREDENCE trials. Manufactured by Cipla and Natco for diabetes export.
Respiratory
95 products available
TabletMontelukast 10mg
Montelukast Sodium
Cysteinyl leukotriene receptor-1 antagonist that blocks the bronchoconstrictive and pro-inflammatory effects of leukotrienes, providing once-daily prophylactic control of asthma and allergic rhinitis. Particularly valuable in aspirin-exacerbated respiratory disease and exercise-induced bronchoconstriction, with convenient oral dosing versus inhaled alternatives.
InhalerSalbutamol Inhaler 100mcg
Salbutamol Sulfate
Short-acting beta-2 agonist bronchodilator delivering rapid bronchospasm relief within 5 minutes, the universal rescue therapy for acute asthma and COPD endorsed by GINA and GOLD guidelines globally. India's Cipla pioneered affordable HFA-propellant generics that made this life-saving inhaler accessible across low-income countries worldwide.
InhalerBudesonide Inhaler 200mcg
Budesonide
First WHO Essential Medicines-listed inhaled corticosteroid with a well-characterized multi-decade safety profile for asthma prophylaxis, including use during pregnancy. Also available as nebulization respules for pediatric asthma management and as Symbicort (budesonide/formoterol) combination, one of the world's most prescribed respiratory products.
InhalerFluticasone Propionate 125mcg
Fluticasone Propionate
One of the most potent inhaled corticosteroids with high glucocorticoid receptor affinity and extensive first-pass hepatic metabolism ensuring minimal systemic bioavailability at therapeutic doses. Cornerstone of the globally dominant Seretide/Advair fixed-dose combination with salmeterol, widely used in chronic severe asthma and COPD step-up therapy.
TabletTheophylline SR 300mg
Theophylline Anhydrous
Methylxanthine bronchodilator and anti-inflammatory agent providing sustained bronchodilation through phosphodiesterase inhibition and adenosine receptor antagonism, with a decades-long role in asthma and COPD management worldwide. Cost-effectiveness and availability in sustained-release oral forms maintain clinical relevance in resource-limited settings despite its narrow therapeutic index.
SachetAcetylcysteine 600mg Sachet
N-Acetylcysteine
Versatile thiol-containing compound acting simultaneously as a mucolytic (cleaving mucus disulfide bonds), antioxidant (glutathione precursor), and life-saving antidote in paracetamol overdose. The 600mg once-daily effervescent sachet formulation dominates COPD and chronic bronchitis management across European and Asian export markets.
TabletDoxofylline 400mg
Doxofylline
7-dioxolane derivative xanthine bronchodilator offering comparable bronchodilation to theophylline but with substantially lower phosphodiesterase inhibition at cardiac and GI receptor sites, resulting in improved GI and cardiovascular tolerability. Therapeutic drug monitoring is generally not required, simplifying clinical management in COPD and asthma patients.
InhalerLevosalbutamol 1mg Inhaler
Levosalbutamol Sulfate
Pharmacologically active R-enantiomer of racemic salbutamol, delivering equivalent or superior bronchodilation at half the dose while eliminating the pro-bronchoconstrictive S-enantiomer. Preferred for nebulization in pediatric acute asthma and in patients with cardiac comorbidities who cannot tolerate the tachycardic effects of racemic salbutamol.
Capsule for inhalationTiotropium Bromide 18mcg
Tiotropium Bromide
Long-acting muscarinic antagonist (LAMA) providing 24-hour bronchodilation via once-daily inhalation for COPD maintenance. Manufactured by Cipla and Sun Pharma for respiratory export.
InhalerBudesonide + Formoterol 200/6mcg
Budesonide + Formoterol Fumarate
ICS-LABA combination inhaler for maintenance and reliever therapy (MART) in asthma and COPD. Manufactured by Cipla and Sun Pharma for respiratory export.
TabletBambuterol 10mg
Bambuterol Hydrochloride
Long-acting prodrug of terbutaline providing sustained 24-hour bronchodilation with once-daily oral dosing for nocturnal asthma. Manufactured by Sun Pharma for respiratory export.
CapsulePirfenidone 200mg
Pirfenidone
Anti-fibrotic agent that reduces TGF-beta and TNF-alpha to slow progression of idiopathic pulmonary fibrosis. Manufactured by Cipla and Sun Pharma for pulmonology export.
Gastrointestinal
99 products available
CapsuleOmeprazole 20mg
Omeprazole
Proton pump inhibitor that irreversibly inhibits the gastric H+/K+-ATPase enzyme, achieving over 90% acid suppression and revolutionizing the treatment of acid-peptic diseases since its launch. The world's most prescribed PPI and a WHO Essential Medicine, with India being a major global supplier of affordable omeprazole capsule and injectable formulations.
TabletEsomeprazole 40mg
Esomeprazole Magnesium
S-enantiomer of omeprazole with reduced first-pass metabolism delivering higher and more consistent plasma levels than racemic omeprazole, resulting in superior acid suppression for erosive esophagitis healing. The enteric-coated tablet formulation enables convenient once-daily dosing with consistently better gastric acid control across CYP2C19 genetic polymorphism groups.
TabletRabeprazole 20mg
Rabeprazole Sodium
Non-enzymatic, non-CYP2C19-dependent PPI that undergoes predominantly non-enzymatic metabolism, providing more predictable and consistent acid suppression across all patient genetic phenotypes compared to other PPIs. Preferred in patients on clopidogrel (reduced drug interaction risk) and in CYP2C19 poor/ultra-rapid metabolizers.
TabletDomperidone 10mg
Domperidone
Peripheral dopamine D2-receptor antagonist that accelerates gastric emptying and enhances lower esophageal sphincter tone without crossing the blood-brain barrier to any significant extent, minimizing CNS side effects compared to metoclopramide. Widely prescribed in India and Africa as a combination with PPIs for GERD and functional dyspepsia symptom management.
TabletSucralfate 1g Tablet
Sucralfate
Sucrose aluminum complex that forms a viscous, adhesive gel barrier selectively binding to ulcer craters and protecting them from acid, pepsin, and bile acids — a unique cytoprotective mechanism independent of acid suppression. Preferred when acid suppression is contraindicated or as adjunct therapy, and particularly valued for stress ulcer prophylaxis in ICU settings.
TabletMesalamine 400mg
Mesalamine (5-Aminosalicylic Acid)
Topically acting aminosalicylate that inhibits NF-kB-mediated mucosal inflammation in the colon, forming the cornerstone of mild-to-moderate ulcerative colitis management for both induction and long-term remission maintenance. Available across multiple delivery forms — delayed-release oral tablets, rectal suppositories, and enemas — enabling targeted therapy based on disease extent.
SachetRacecadotril 100mg
Racecadotril (Acetorphan)
Prodrug enkephalinase inhibitor that potentiates intestinal enkephalins to reduce hypersecretion while completely preserving normal intestinal motility, offering an advantage over loperamide which causes post-treatment constipation. Particularly valuable in acute pediatric secretory diarrhea where it is available in weight-adjusted sachets across multiple age groups.
TabletOndansetron 8mg
Ondansetron Hydrochloride
Selective 5-HT3 receptor antagonist antiemetic for chemotherapy-induced and post-operative nausea and vomiting. Manufactured by Cipla and Sun Pharma for oncology and hospital export.
TabletItopride 50mg
Itopride Hydrochloride
Prokinetic agent with dual mechanism (D2 antagonism + acetylcholinesterase inhibition) for functional dyspepsia and gastroparesis. Manufactured by Sun Pharma and Torrent for GI export.
CapsuleAlvimopan 12mg
Alvimopan
Peripherally acting mu-opioid receptor antagonist for accelerating GI recovery after bowel surgery. Manufactured by Indian pharmaceutical companies for hospital export.
TabletMesalamine 800mg DR
Mesalamine
High-strength delayed-release mesalamine tablet for reduced pill burden in ulcerative colitis management. Manufactured by Sun Pharma and Cipla for gastroenterology export.
Antiviral
81 products available
TabletAcyclovir 400mg
Acyclovir
First clinically successful selective antiviral and WHO Essential Medicine — a guanosine analog phosphorylated exclusively by herpes-virus thymidine kinase to specifically inhibit viral DNA polymerase. Foundational therapy for HSV and VZV infections across all age groups with a four-decade safety record in oral and intravenous formulations.
TabletValacyclovir 500mg
Valacyclovir Hydrochloride
L-valyl ester prodrug of acyclovir with 3-5 times higher oral bioavailability, enabling simplified twice or three-times-daily dosing versus acyclovir's five-daily regimen. Preferred for herpes zoster management and uniquely effective as single-day therapy for herpes labialis, significantly improving patient adherence over standard acyclovir courses.
CapsuleOseltamivir 75mg
Oseltamivir Phosphate
Competitive neuraminidase inhibitor preventing influenza virus budding and spread from infected respiratory cells, reducing illness duration by 1-2 days when initiated within 48 hours of symptom onset. WHO pandemic stockpile antiviral recommended as first-line treatment for severe influenza in high-risk populations including the elderly, immunocompromised, and young children.
TabletFavipiravir 400mg
Favipiravir
Broad-spectrum RNA-dependent RNA polymerase inhibitor that is incorporated into viral RNA as a fraudulent purine nucleotide, causing lethal mutagenesis across multiple RNA viruses. Approved in Japan for influenza and granted emergency use authorization in India and Russia for COVID-19, with Glenmark and Cipla among India's first manufacturers to supply this strategic antiviral.
CapsuleMolnupiravir 200mg
Molnupiravir
Oral nucleoside analog prodrug that introduces copying errors into SARS-CoV-2 RNA via lethal mutagenesis. Manufactured by Dr. Reddy's and Cipla for COVID-19 treatment export.
InjectionRemdesivir 100mg Injection
Remdesivir
Nucleotide analog RNA polymerase inhibitor for hospitalized COVID-19 patients requiring supplemental oxygen. Manufactured by Cipla and Hetero for hospital export.
TabletEntecavir 0.5mg
Entecavir
Guanosine nucleoside analog with potent and selective activity against HBV polymerase for chronic hepatitis B treatment. Manufactured by Cipla and Zydus for hepatology export.
InjectionGanciclovir 500mg Injection
Ganciclovir Sodium
Nucleoside analog active against CMV for treatment of CMV retinitis and prophylaxis in transplant recipients. Manufactured by Cipla for hospital infectious disease export.
HIV / Antiretroviral
68 products available
TabletEfavirenz 600mg
Efavirenz
Second-generation NNRTI that allosterically inhibits HIV-1 reverse transcriptase, a backbone of PEPFAR-supported first-line HIV treatment in sub-Saharan Africa and Southeast Asia. Available in the landmark fixed-dose combination TDF/3TC/EFV (Atripla/generic), which transformed HIV care globally with a once-daily single-pill regimen.
TabletLopinavir + Ritonavir 200/50mg
Lopinavir + Ritonavir
Fixed-dose combination where sub-therapeutic ritonavir inhibits CYP3A4 to dramatically boost lopinavir plasma levels, achieving reliable viral suppression without food restrictions for the tablet formulation. Widely used in pediatric HIV as oral solution and an affordable PEPFAR-supported generic in resource-limited settings globally.
CapsuleAtazanavir + Ritonavir 300/100mg
Atazanavir + Ritonavir
Ritonavir-boosted azapeptide protease inhibitor distinguished by its unique pharmacokinetic characteristic of causing benign indirect hyperbilirubinemia (marker of absorption), once-daily dosing convenience, and a significantly more favorable lipid profile than lopinavir/ritonavir. Preferred second-line choice in resource-limited settings and in patients with dyslipidemia or cardiovascular risk.
TabletAbacavir + Lamivudine 600/300mg
Abacavir + Lamivudine
Dual NRTI backbone combining abacavir and lamivudine in a once-daily tablet forming the nucleoside backbone of multiple WHO-recommended HIV regimens. Mandatory HLA-B*5701 pharmacogenomic screening before use is required to prevent the potentially fatal abacavir hypersensitivity syndrome — a landmark example of precision medicine applied in HIV therapy.
TabletDolutegravir + Lamivudine + TDF
Dolutegravir + Lamivudine + Tenofovir DF
WHO-recommended first-line single-tablet ART regimen combining INSTI with dual NRTI backbone for treatment-naive HIV patients. Manufactured by Cipla and Hetero for global HIV program export.
TabletDarunavir 600mg
Darunavir Ethanolate
Second-generation HIV protease inhibitor with high genetic barrier to resistance, recommended as preferred PI for second-line ART. Manufactured by Hetero and Cipla for HIV program export.
TabletRaltegravir 400mg
Raltegravir Potassium
First-in-class integrase strand transfer inhibitor (INSTI) for HIV treatment with minimal drug interactions. Manufactured by Cipla and Hetero for HIV program export.
Vitamins & Supplements
80 products available
SachetCholecalciferol 60,000 IU Sachet
Cholecalciferol (Vitamin D3)
High-potency cholecalciferol sachet providing the natural animal-derived form of vitamin D proven superior to ergocalciferol (D2) in raising and sustaining serum 25(OH)D levels. The 60,000 IU weekly sachet is the most widely prescribed vitamin D replacement format in India for moderate-to-severe deficiency correction, dissolved in water or milk for immediate oral intake.
TabletCalcium Carbonate + Vitamin D3
Calcium Carbonate + Cholecalciferol
Synergistic combination of calcium carbonate providing high elemental calcium content (40% elemental) with cholecalciferol essential for intestinal calcium absorption, forming the cornerstone of osteoporosis prevention and adjunct treatment alongside bisphosphonates. Recommended universally for post-menopausal women, elderly populations, and patients on long-term corticosteroid therapy.
TabletFerrous Ascorbate + Folic Acid
Ferrous Ascorbate + Folic Acid
Premium iron supplement in the ferrous ascorbate form, where the ascorbate moiety maintains iron in the ferrous (Fe2+) oxidation state for 3-4 times superior gastrointestinal absorption compared to ferrous sulfate, with significantly fewer GI side effects. Combined with 1.5mg folic acid making it the preferred choice for iron-deficiency anemia in pregnancy and lactation.
CapsuleOmega-3 Fatty Acids 1000mg
Omega-3 Fatty Acids (EPA + DHA)
Purified marine-derived EPA and DHA polyunsaturated fatty acids that reduce triglyceride synthesis in the liver by 20-50% at prescription doses, with additional anti-inflammatory, antiplatelet, and cardioprotective effects confirmed in large cardiovascular outcome trials. High-concentration EPA formulations (icosapentaenoic acid) have demonstrated significant cardiovascular mortality benefits in statin-treated patients.
TabletMethylcobalamin 1500mcg
Methylcobalamin (Vitamin B12)
Biologically active coenzyme form of vitamin B12 directly participating in myelin synthesis and methionine regeneration without hepatic conversion unlike cyanocobalamin. Clinically preferred for neuropathic indications over cyanocobalamin and widely prescribed across India, Japan, and Southeast Asia as the gold-standard B12 supplement for peripheral and diabetic neuropathy.
TabletB-Complex + Zinc Tablet
Vitamin B-Complex + Zinc
Complete water-soluble vitamin complex addressing all eight essential B vitamins together with zinc, a cofactor for over 300 enzymatic reactions critical to immune defense, wound healing, and protein synthesis. Widely indicated across Southeast Asian and African markets where combined B-vitamin and zinc deficiencies are common, particularly in malnourished and elderly patients.
InjectionIron Sucrose 100mg Injection
Iron Sucrose
IV iron complex for rapid correction of iron deficiency anemia when oral iron is insufficient or not tolerated. Manufactured by Emcure and Cipla for hospital hematology export.
CapsuleAlfacalcidol 0.25mcg
Alfacalcidol
1-alpha-hydroxylated vitamin D3 analog requiring only hepatic 25-hydroxylation for activation, suitable for patients with renal impairment. Manufactured by Sun Pharma for endocrinology export.
TabletZinc + Vitamin C Tablets
Zinc Gluconate + Ascorbic Acid
Immune support combination of zinc and vitamin C for prevention and supportive treatment of common cold and immune deficiency. Manufactured by Mankind and Alkem for health supplement export.
Anti-Allergic & Immunology
28 products available
TabletFexofenadine 180mg
Fexofenadine Hydrochloride
Second-generation antihistamine offering 24-hour relief from allergic rhinitis and chronic idiopathic urticaria without causing sedation or impaired psychomotor performance. Preferred in clinical practice for its rapid onset of action, excellent cardiac safety profile, and absence of anticholinergic effects.
TabletDesloratadine 5mg
Desloratadine
Active primary metabolite of loratadine with superior potency and a longer duration of action, providing once-daily control of seasonal and perennial allergic rhinitis as well as chronic idiopathic urticaria. Its minimal CNS penetration ensures full alertness throughout the day, making it suitable for patients who require sustained performance at work or while driving.
TabletMontelukast + Levocetirizine
Montelukast + Levocetirizine
Dual-mechanism fixed-dose combination that blocks both leukotriene receptors and histamine H1 receptors, delivering superior allergy control over either agent alone. Particularly effective in patients with coexisting allergic rhinitis and mild persistent asthma, offering nighttime symptom relief when taken once daily in the evening.
TabletBilastine 20mg
Bilastine
Newest-generation non-sedating antihistamine with a pharmacological profile distinct from older agents, including absence of QT prolongation and no clinically relevant drug interactions. Its unique P-glycoprotein substrate nature minimises CNS penetration, making it the preferred choice for professionals, pilots, and patients requiring sustained alertness throughout the day.
TabletHydroxyzine 25mg
Hydroxyzine Hydrochloride
First-generation piperazine antihistamine with potent H1-blocking and anxiolytic activity, widely used for pruritus management, pre-operative sedation, and short-term anxiety relief. Its rapid onset of sedation makes it particularly valuable in dermatological practice for refractory pruritus and in surgical settings as an effective non-opioid anxiolytic adjunct.
TabletRupatadine 10mg
Rupatadine Fumarate
Dual-action antihistamine with additional PAF (platelet-activating factor) antagonism for enhanced anti-allergic and anti-inflammatory activity. Manufactured by Glenmark for allergy export.
TabletEbastine 20mg
Ebastine
Long-acting second-generation antihistamine with once-daily dosing and low sedation profile for allergic rhinitis and urticaria. Manufactured by Sun Pharma for allergy export.
Urology & Nephrology
20 products available
CapsuleDutasteride 0.5mg
Dutasteride
Dual-isoform 5-alpha reductase inhibitor (types I and II) providing more complete DHT suppression than finasteride, leading to clinically significant prostate volume reduction and improved urinary flow in benign prostatic hyperplasia. Long-term therapy reduces the risk of acute urinary retention and the need for surgical intervention, with benefit becoming evident after 3-6 months of continuous treatment.
TabletSolifenacin 5mg
Solifenacin Succinate
Selective M3 muscarinic receptor antagonist that reduces detrusor muscle overactivity, providing clinically meaningful reductions in urinary urgency episodes, voiding frequency, and urge incontinence. Once-daily dosing with a long half-life ensures consistent 24-hour bladder control, and the dose can be titrated from 5mg to 10mg based on individual response and tolerability.
TabletPotassium Citrate 1080mg
Potassium Citrate
Extended-release urinary alkalinizer that raises urinary pH and citrate concentration to inhibit calcium oxalate and uric acid crystal formation, significantly reducing recurrence rates of nephrolithiasis. The wax-matrix formulation ensures sustained alkalinisation throughout the day, making compliance straightforward with twice or thrice daily dosing alongside meals.
TabletMirabegron 50mg
Mirabegron
First beta-3 adrenoceptor agonist for overactive bladder providing an alternative to antimuscarinics without dry mouth or constipation. Manufactured by Sun Pharma for urology export.
TabletAlfuzosin 10mg
Alfuzosin Hydrochloride
Uroselective alpha-1 blocker for symptomatic BPH with lower orthostatic hypotension risk than non-selective alpha blockers. Manufactured by Sun Pharma and Cipla for urology export.
TabletDesmopressin 0.2mg
Desmopressin Acetate
Synthetic vasopressin analog for nocturnal enuresis and central diabetes insipidus with enhanced antidiuretic potency and minimal vasopressor activity. Manufactured by Sun Pharma for endocrinology/urology export.
Hepatology & Liver Care
19 products available
TabletSilymarin 140mg
Silymarin (Milk Thistle Extract)
Standardised flavonolignan complex extracted from Silybum marianum that exerts hepatoprotection through antioxidant activity, membrane stabilisation, and inhibition of hepatotoxin uptake into hepatocytes. Widely used as an adjunct in alcoholic liver disease, drug-induced liver injury, and non-alcoholic fatty liver disease, with a well-established safety profile supporting long-term use.
SachetL-Ornithine L-Aspartate
L-Ornithine L-Aspartate (LOLA)
Amino acid combination that stimulates the urea cycle and hepatic glutamine synthesis to accelerate ammonia detoxification in patients with liver cirrhosis and subclinical or overt hepatic encephalopathy. Clinical evidence supports its use as an adjunct to lactulose and rifaximin, with oral sachets offering convenient outpatient management of chronic hyperammonaemia.
SyrupLactulose Solution 10g/15ml
Lactulose
Non-absorbable synthetic disaccharide acting as both an osmotic laxative and an ammonia-lowering agent, making it a dual-indication first-line therapy for chronic constipation and hepatic encephalopathy. By acidifying colonic content and converting ammonia to non-absorbable ammonium ions, it significantly reduces systemic ammonia load and improves neurological function in cirrhotic patients.
TabletTenofovir Alafenamide 25mg
Tenofovir Alafenamide
Next-generation tenofovir prodrug with targeted hepatic delivery providing equivalent HBV suppression at 1/10th the dose of TDF with significantly less bone and renal toxicity. Manufactured by Cipla and Hetero for hepatology export.
TabletS-Adenosylmethionine 400mg
S-Adenosylmethionine (SAMe)
Naturally occurring methyl donor involved in hepatic transmethylation and transsulfuration pathways for intrahepatic cholestasis and liver disease adjunct therapy. Manufactured by Sun Pharma for hepatology export.
Musculoskeletal & Orthopedic
16 products available
TabletColchicine 0.5mg
Colchicine
Plant-derived anti-inflammatory alkaloid that inhibits microtubule polymerisation and neutrophil degranulation, providing rapid and effective relief of acute gouty arthritis within hours of administration. Beyond gout, it has proven efficacy in reducing pericarditis recurrence and is the treatment of choice for familial Mediterranean fever, with a narrow therapeutic index requiring careful dose titration.
TabletCalcium + Calcitriol
Calcium Carbonate + Calcitriol
Fixed-dose combination of elemental calcium with calcitriol, the hormonally active form of vitamin D3 that bypasses both hepatic and renal hydroxylation steps, making it the preparation of choice in chronic kidney disease mineral bone disorder and hypoparathyroidism. Direct stimulation of intestinal calcium absorption and bone mineralisation is achieved even in patients with severely impaired renal 1-alpha-hydroxylase activity.
TabletAlendronate 70mg
Alendronate Sodium
Nitrogen-containing bisphosphonate that potently inhibits osteoclast-mediated bone resorption, with landmark clinical trials demonstrating significant reductions in vertebral and hip fracture risk in postmenopausal osteoporosis. The 70mg once-weekly formulation substantially improves patient adherence compared to daily dosing while delivering equivalent anti-resorptive efficacy.
InjectionDenosumab 60mg Injection
Denosumab
RANKL monoclonal antibody inhibiting osteoclast formation for osteoporosis treatment with twice-yearly subcutaneous dosing. Manufactured by Biocon and Cipla for orthopedic/rheumatology export.
InjectionTeriparatide 20mcg Injection
Teriparatide (PTH 1-34)
Recombinant parathyroid hormone fragment that stimulates new bone formation (anabolic agent) for severe osteoporosis. Manufactured by Intas and Biocon for osteoporosis export.
TabletLeflunomide 20mg
Leflunomide
Pyrimidine synthesis inhibitor DMARD for rheumatoid arthritis as alternative to methotrexate with less hepatotoxicity. Manufactured by Sun Pharma and Cipla for rheumatology export.
Need a product not listed here?
We can source any pharmaceutical product from certified Indian manufacturers.